CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | 1,2-epoxypropane |
|
Accession: | CHEBI:38685
|
browse the term
|
Definition: | An epoxide that is oxirane substituted by a methyl group at position 2. |
Synonyms: | exact_synonym: | 2-methyloxirane |
| related_synonym: | 1,2-propylene oxide; 2,3-epoxypropane; Formula=C3H6O; InChI=1S/C3H6O/c1-3-2-4-3/h3H,2H2,1H3; InChIKey=GOOHAUXETOMSMM-UHFFFAOYSA-N; SMILES=[H]C1(C)CO1; epoxypropane; methyloxacyclopropane; methyloxirane; propylene oxide |
| alt_id: | CHEBI:11158; CHEBI:23934 |
| xref: | Beilstein:79763; CAS:75-56-9; Gmelin:81761; HMDB:HMDB0031558; KEGG:C15508; MetaCyc:12-EPOXYPROPANE; PMID:23803541; PMID:24699862; Reaxys:79763; Wikipedia:Propylene_oxide |
|
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of AMPD3 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of APAF1 mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of BAK1 mRNA |
CTD |
PMID:29792945 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
Epichlorohydrin results in increased expression of BAX mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of BBC3 mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression |
ISO |
Epichlorohydrin results in increased expression of BCL2 mRNA |
CTD |
PMID:29792945 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
decreases expression |
ISO |
Epichlorohydrin results in decreased expression of BCL2L11 mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bok |
BCL2 family apoptosis regulator BOK |
increases expression |
ISO |
Epichlorohydrin results in increased expression of BOK mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 9:94,223,493...94,234,476
Ensembl chr 9:94,223,389...94,234,476
|
|
G |
Casp2 |
caspase 2 |
decreases expression |
ISO |
Epichlorohydrin results in decreased expression of CASP2 mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp8 |
caspase 8 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of CASP8 mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of CASP9 mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Chst11 |
carbohydrate sulfotransferase 11 |
affects response to substance |
ISO |
CHST11 gene SNP affects the susceptibility to Epichlorohydrin |
CTD |
PMID:25622337 |
|
NCBI chr 7:20,524,535...20,743,008
Ensembl chr 7:20,528,100...20,743,111
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
decreases expression |
ISO |
Epichlorohydrin results in decreased expression of DIABLO mRNA |
CTD |
PMID:29792945 |
|
NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dner |
delta/notch-like EGF repeat containing |
affects response to substance |
ISO |
DNER gene SNP affects the susceptibility to Epichlorohydrin |
CTD |
PMID:25622337 |
|
NCBI chr 9:85,586,985...85,902,461
Ensembl chr 9:85,586,987...85,902,637
|
|
G |
Fth1 |
ferritin heavy chain 1 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of FTH1 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of FTL mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Epichlorohydrin results in increased expression of GCLM mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects response to substance |
ISO |
GSTM1 gene polymorphism affects the susceptibility to Epichlorohydrin |
CTD |
PMID:15091291 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of HMOX1 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Kcp |
kielin cysteine rich BMP regulator |
affects response to substance |
ISO |
KCP gene SNP affects the susceptibility to Epichlorohydrin |
CTD |
PMID:25622337 |
|
NCBI chr 4:58,082,856...58,118,170
Ensembl chr 4:58,082,857...58,109,768
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression |
ISO |
Epichlorohydrin results in increased expression of MYC mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of NQO1 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Sel1l3 |
SEL1L family member 3 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of SEL1L3 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of SLC7A11 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of SQSTM1 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Syne2 |
spectrin repeat containing nuclear envelope protein 2 |
decreases expression |
ISO |
Epichlorohydrin results in decreased expression of SYNE2 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064
|
|
G |
Tank |
TRAF family member-associated NFKB activator |
increases expression |
ISO |
Epichlorohydrin results in increased expression of TANK mRNA |
CTD |
PMID:29792945 |
|
NCBI chr 3:46,114,230...46,190,270
Ensembl chr 3:46,114,274...46,190,264
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
decreases expression |
ISO |
Epichlorohydrin results in decreased expression of TNFRSF10A mRNA |
CTD |
PMID:22723965 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tnfrsf9 |
TNF receptor superfamily member 9 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of TNFRSF9 mRNA |
CTD |
PMID:22723965 |
|
NCBI chr 5:161,381,662...161,408,003
Ensembl chr 5:161,381,662...161,408,000
|
|
G |
Tnnt2 |
troponin T2, cardiac type |
decreases expression |
ISO |
Epichlorohydrin results in decreased expression of TNNT2 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
Epichlorohydrin results in increased expression of TXNRD1 mRNA |
CTD |
PMID:24211530 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
|
G |
Aard |
alanine and arginine rich domain containing protein |
decreases expression |
EXP |
glycidol results in decreased expression of AARD mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:83,364,478...83,369,319
Ensembl chr 7:83,364,204...83,369,317
|
|
G |
Abcg3l4 |
ATP-binding cassette, subfamily G (WHITE), member 3-like 4 |
decreases expression |
EXP |
glycidol results in decreased expression of ABCG3L4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr14:4,545,206...4,590,223
Ensembl chr14:4,545,223...4,585,347
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
increases expression |
EXP |
glycidol results in increased expression of ACADS mRNA |
CTD |
PMID:24915197 |
|
NCBI chr12:41,493,650...41,502,897
Ensembl chr12:41,493,626...41,502,898
|
|
G |
Ace |
angiotensin I converting enzyme |
increases expression |
EXP |
glycidol results in increased expression of ACE mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of ACSL4 mRNA glycidol results in increased methylation of ACSL4 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of ACSM3 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
|
|
G |
Acsm5 |
acyl-CoA synthetase medium-chain family member 5 |
increases expression |
EXP |
glycidol results in increased expression of ACSM5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588
|
|
G |
Acvr1c |
activin A receptor type 1C |
increases expression |
EXP |
glycidol results in increased expression of ACVR1C mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327
|
|
G |
Adad2 |
adenosine deaminase domain containing 2 |
increases expression |
EXP |
glycidol results in increased expression of ADAD2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr19:47,665,288...47,669,433
Ensembl chr19:47,665,309...47,669,436
|
|
G |
Adam7 |
ADAM metallopeptidase domain 7 |
decreases expression |
EXP |
glycidol results in decreased expression of ADAM7 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
decreases expression |
EXP |
glycidol results in decreased expression of ADAMTS1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Adamts9 |
ADAM metallopeptidase with thrombospondin type 1 motif, 9 |
decreases expression |
EXP |
glycidol results in decreased expression of ADAMTS9 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
|
|
G |
Adcy8 |
adenylate cyclase 8 |
decreases expression |
EXP |
glycidol results in decreased expression of ADCY8 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:96,417,310...96,665,911
Ensembl chr 7:96,417,324...96,665,911
|
|
G |
Adcyap1r1 |
ADCYAP receptor type I |
decreases expression |
EXP |
glycidol results in decreased expression of ADCYAP1R1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700
|
|
G |
Adra1b |
adrenoceptor alpha 1B |
decreases expression |
EXP |
glycidol results in decreased expression of ADRA1B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:28,255,025...28,373,418
Ensembl chr10:28,255,025...28,312,919
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
decreases expression |
EXP |
glycidol results in decreased expression of ADRA2A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:253,061,480...253,064,280
Ensembl chr 1:253,060,218...253,064,365
|
|
G |
Afdn |
afadin, adherens junction formation factor |
increases expression decreases expression increases methylation |
EXP |
glycidol results in increased expression of AFDN mRNA glycidol results in decreased expression of AFDN mRNA glycidol results in increased methylation of AFDN promoter |
CTD |
PMID:24915197 PMID:33150595 PMID:33150645 |
|
NCBI chr 1:53,905,344...54,034,216
Ensembl chr 1:53,905,373...54,034,216
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
decreases expression |
EXP |
glycidol results in decreased expression of AGTR2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
increases expression |
EXP |
glycidol results in increased expression of AIFM1 protein |
CTD |
PMID:34461274 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ak8 |
adenylate kinase 8 |
increases expression |
EXP |
glycidol results in increased expression of AK8 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:12,028,895...12,144,468
Ensembl chr 3:12,028,954...12,144,465
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
EXP |
glycidol results in decreased expression of AKT1 mRNA |
CTD |
PMID:34461274 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
increases expression |
EXP |
glycidol results in increased expression of ALB mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase 3 family, member A1 |
decreases expression |
EXP |
glycidol results in decreased expression of ALDH3A1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
|
|
G |
Alpk3 |
alpha-kinase 3 |
decreases expression |
EXP |
glycidol results in decreased expression of ALPK3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:135,014,455...135,062,294
Ensembl chr 1:135,014,499...135,062,302
|
|
G |
Alx3 |
ALX homeobox 3 |
decreases expression |
EXP |
glycidol results in decreased expression of ALX3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:195,231,197...195,241,609
Ensembl chr 2:195,231,197...195,241,609
|
|
G |
Amigo1 |
adhesion molecule with Ig like domain 1 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of AMIGO1 promoter glycidol results in decreased expression of AMIGO1 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 2:195,823,138...195,828,593
Ensembl chr 2:195,823,042...195,829,585
|
|
G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
increases expression decreases expression increases methylation |
EXP |
glycidol results in increased expression of AMIGO2 mRNA glycidol results in decreased expression of AMIGO2 mRNA glycidol results in increased methylation of AMIGO2 promoter |
CTD |
PMID:24915197 PMID:33150595 PMID:33150645 |
|
NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695
|
|
G |
Angpt4 |
angiopoietin 4 |
decreases expression |
EXP |
glycidol results in decreased expression of ANGPT4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:140,420,389...140,454,213
Ensembl chr 3:140,420,389...140,453,583
|
|
G |
Ankrd66 |
ankyrin repeat domain 66 |
decreases expression |
EXP |
glycidol results in decreased expression of ANKRD66 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:17,421,432...17,441,212
Ensembl chr 9:17,411,983...17,442,647
|
|
G |
Ano1 |
anoctamin 1 |
decreases expression |
EXP |
glycidol results in decreased expression of ANO1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069
|
|
G |
Ano7 |
anoctamin 7 |
decreases expression |
EXP |
glycidol results in decreased expression of ANO7 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:93,917,524...93,945,323
Ensembl chr 9:93,917,524...93,945,323
|
|
G |
Aox1 |
aldehyde oxidase 1 |
increases expression |
EXP |
glycidol results in increased expression of AOX1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 9:59,579,621...59,658,772
Ensembl chr 9:59,579,649...59,658,770
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression |
EXP |
glycidol results in decreased expression of APOA1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
|
|
G |
Apoa5 |
apolipoprotein A5 |
decreases expression |
EXP |
glycidol results in decreased expression of APOA5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
increases expression |
EXP |
glycidol results in increased expression of APOBEC1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
|
|
G |
Apoe |
apolipoprotein E |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of APOE promoter glycidol results in decreased expression of APOE mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Apol9a |
apolipoprotein L9a |
decreases expression |
EXP |
glycidol results in decreased expression of APOL9A mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
decreases expression |
EXP |
glycidol results in decreased expression of APOLD1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
EXP |
glycidol results in increased expression of AQP1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Arc |
activity-regulated cytoskeleton-associated protein |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of ARC mRNA glycidol results in increased methylation of ARC promoter |
CTD |
PMID:24915197 PMID:33150595 PMID:33150645 |
|
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
|
|
G |
Arfgef2 |
ADP ribosylation factor guanine nucleotide exchange factor 2 |
increases expression |
EXP |
glycidol results in increased expression of ARFGEF2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:155,547,504...155,633,652
Ensembl chr 3:155,547,538...155,630,856
|
|
G |
Arg1 |
arginase 1 |
increases expression |
EXP |
glycidol results in increased expression of ARG1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arg2 |
arginase 2 |
increases expression |
EXP |
glycidol results in increased expression of ARG2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
|
|
G |
Arhgap28 |
Rho GTPase activating protein 28 |
decreases expression |
EXP |
glycidol results in decreased expression of ARHGAP28 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:107,832,584...107,998,030
Ensembl chr 9:107,833,330...107,998,000
|
|
G |
Arhgap31 |
Rho GTPase activating protein 31 |
increases expression |
EXP |
glycidol results in increased expression of ARHGAP31 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr11:62,038,635...62,151,564
Ensembl chr11:62,038,635...62,151,564
|
|
G |
Arhgap4 |
Rho GTPase activating protein 4 |
increases expression |
EXP |
glycidol results in increased expression of ARHGAP4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:151,636,071...151,651,528
Ensembl chr X:151,632,454...151,651,128
|
|
G |
Arid3a |
AT-rich interaction domain 3A |
increases expression |
ISO |
glycidol results in increased expression of ARID3A mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
|
|
G |
Arl4d |
ADP-ribosylation factor like GTPase 4D |
increases expression |
EXP |
glycidol results in increased expression of ARL4D mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
|
|
G |
Arrdc3 |
arrestin domain containing 3 |
decreases expression |
EXP |
glycidol results in decreased expression of ARRDC3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
|
|
G |
Art5 |
ADP-ribosyltransferase 5 |
decreases expression |
EXP |
glycidol results in decreased expression of ART5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:156,473,362...156,483,324
Ensembl chr 1:156,473,362...156,483,324
|
|
G |
Arx |
aristaless related homeobox |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of ARX mRNA glycidol results in increased methylation of ARX promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr X:58,016,233...58,028,149
Ensembl chr X:58,016,233...58,028,142
|
|
G |
Ascc2 |
activating signal cointegrator 1 complex subunit 2 |
decreases expression |
EXP |
glycidol results in decreased expression of ASCC2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:79,503,449...79,547,801
Ensembl chr14:79,503,517...79,545,494
|
|
G |
Astl |
astacin like metalloendopeptidase |
decreases expression |
EXP |
glycidol results in decreased expression of ASTL mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:114,563,135...114,580,295
Ensembl chr 3:114,563,135...114,578,868
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
EXP |
glycidol results in decreased expression of ATF3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atoh7 |
atonal bHLH transcription factor 7 |
increases expression |
EXP |
glycidol results in increased expression of ATOH7 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr20:25,530,826...25,531,275
Ensembl chr20:25,530,826...25,531,275
|
|
G |
Atp12a |
ATPase H+/K+ transporting non-gastric alpha2 subunit |
decreases expression |
EXP |
glycidol results in decreased expression of ATP12A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229
|
|
G |
Atp2b2 |
ATPase plasma membrane Ca2+ transporting 2 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of ATP2B2 promoter glycidol results in decreased expression of ATP2B2 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
|
|
G |
Atp4a |
ATPase H+/K+ transporting subunit alpha |
decreases expression |
EXP |
glycidol results in decreased expression of ATP4A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:85,961,607...85,974,972
Ensembl chr 1:85,961,708...85,974,844
|
|
G |
Atp7b |
ATPase copper transporting beta |
decreases expression |
EXP |
glycidol results in decreased expression of ATP7B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
Aurkb |
aurora kinase B |
decreases expression |
EXP |
glycidol results in decreased expression of AURKB mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
B3galnt2 |
beta-1,3-N-acetylgalactosaminyltransferase 2 |
increases expression |
EXP |
glycidol results in increased expression of B3GALNT2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:51,334,921...51,377,469
Ensembl chr17:51,334,921...51,377,469
|
|
G |
B3gnt4 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 |
decreases expression |
EXP |
glycidol results in decreased expression of B3GNT4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr12:33,070,221...33,073,904
Ensembl chr12:33,060,416...33,073,854
|
|
G |
B3gnt7 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
increases expression |
EXP |
glycidol results in increased expression of B3GNT7 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 9:86,956,220...86,960,171
Ensembl chr 9:86,956,220...86,960,170
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
increases expression |
EXP |
glycidol results in increased expression of BAAT mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
|
|
G |
Baiap2 |
BAR/IMD domain containing adaptor protein 2 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of BAIAP2 mRNA glycidol results in increased methylation of BAIAP2 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
increases expression |
EXP |
glycidol results in increased expression of BASP1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
|
|
G |
Bcan |
brevican |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of BCAN promoter glycidol results in decreased expression of BCAN mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460
|
|
G |
Bcas1 |
brain enriched myelin associated protein 1 |
decreases expression |
EXP |
glycidol results in decreased expression of BCAS1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:159,136,077...159,219,072
Ensembl chr 3:159,136,083...159,219,106
|
|
G |
Bcl11b |
BCL11 transcription factor B |
increases expression |
EXP |
glycidol results in increased expression of BCL11B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:126,834,531...126,927,720
Ensembl chr 6:126,834,531...126,928,224
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
EXP |
glycidol results in decreased expression of BCL2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl6b |
BCL6B, transcription repressor |
decreases expression |
EXP |
glycidol results in decreased expression of BCL6B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:54,940,908...54,947,022
Ensembl chr10:54,940,909...54,945,974
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
decreases expression |
EXP |
glycidol results in decreased expression of BDNF mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
decreases expression |
EXP |
glycidol results in decreased expression of BHLHE22 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:100,486,400...100,489,510
Ensembl chr 2:100,486,400...100,489,510
|
|
G |
Bicral |
BICRA like chromatin remodeling complex associated protein |
increases expression |
EXP |
glycidol results in increased expression of BICRAL mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:14,100,253...14,185,368
Ensembl chr 9:14,154,209...14,183,671
|
|
G |
Birc7 |
baculoviral IAP repeat-containing 7 |
increases expression |
EXP |
glycidol results in increased expression of BIRC7 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
|
|
G |
Blnk |
B-cell linker |
increases expression |
EXP |
glycidol results in increased expression of BLNK mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
|
|
G |
Bmal2 |
basic helix-loop-helix ARNT like 2 |
decreases expression |
EXP |
glycidol results in decreased expression of BMAL2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:179,699,432...179,747,710
Ensembl chr 4:179,699,502...179,746,949
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of BMI1 promoter glycidol results in decreased expression of BMI1 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Bmp15 |
bone morphogenetic protein 15 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of BMP15 promoter glycidol results in decreased expression of BMP15 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr X:16,169,123...16,174,187
Ensembl chr X:16,169,123...16,174,187
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
decreases expression |
EXP |
glycidol results in decreased expression of BMP4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Bpifa5 |
BPI fold containing family A, member 5 |
decreases expression |
EXP |
glycidol results in decreased expression of BPIFA5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:142,646,103...142,652,884
Ensembl chr 3:142,646,103...142,652,883
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
decreases expression |
EXP |
glycidol results in decreased expression of BTG2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
decreases expression |
EXP |
glycidol results in decreased expression of BUB1B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C1qtnf12 |
C1q and TNF related 12 |
increases expression |
EXP |
glycidol results in increased expression of C1QTNF12 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:166,551,628...166,556,003
Ensembl chr 5:166,551,628...166,556,003
|
|
G |
C3 |
complement C3 |
increases expression |
EXP |
glycidol results in increased expression of C3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
C4a |
complement C4A |
decreases expression |
EXP |
glycidol results in decreased expression of C4A mRNA |
CTD |
PMID:24395379 |
|
NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080
|
|
G |
C8h15orf39 |
similar to human chromosome 15 open reading frame 39 |
increases expression |
EXP |
glycidol results in increased expression of C8H15ORF39 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:57,646,324...57,655,896
Ensembl chr 8:57,645,756...57,655,941
|
|
G |
Calb1 |
calbindin 1 |
decreases expression |
EXP |
glycidol results in decreased expression of CALB1 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
|
|
G |
Calca |
calcitonin-related polypeptide alpha |
decreases expression |
EXP |
glycidol results in decreased expression of CALCA mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105
|
|
G |
Calml4 |
calmodulin-like 4 |
increases expression |
EXP |
glycidol results in increased expression of CALML4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:63,323,426...63,335,234
Ensembl chr 8:63,323,351...63,335,234
|
|
G |
Camk2n1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
decreases expression |
EXP |
glycidol results in decreased expression of CAMK2N1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
decreases expression |
EXP |
glycidol results in decreased expression of CAMK4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
EXP |
glycidol results in increased expression of CAPG mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
|
|
G |
Capn6 |
calpain 6 |
decreases expression |
EXP |
glycidol results in decreased expression of CAPN6 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:107,380,774...107,405,489
Ensembl chr X:107,380,774...107,405,489
|
|
G |
Car4 |
carbonic anhydrase 4 |
decreases expression |
EXP |
glycidol results in decreased expression of CAR4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:69,827,945...69,836,501
Ensembl chr10:69,827,945...69,836,501
|
|
G |
Car6 |
carbonic anhydrase 6 |
decreases expression |
EXP |
glycidol results in decreased expression of CAR6 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644
|
|
G |
Cartpt |
CART prepropeptide |
decreases expression |
EXP |
glycidol results in decreased expression of CARTPT mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:31,255,098...31,290,713
|
|
G |
Casp1 |
caspase 1 |
increases cleavage |
EXP |
glycidol results in increased cleavage of CASP1 protein |
CTD |
PMID:33187795 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
increases expression |
EXP |
glycidol results in increased expression of CASP3 protein |
CTD |
PMID:34461274 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casq1 |
calsequestrin 1 |
decreases expression |
EXP |
glycidol results in decreased expression of CASQ1 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr13:84,670,648...84,680,339
Ensembl chr13:84,670,649...84,680,339
|
|
G |
Catip |
ciliogenesis associated TTC17 interacting protein |
decreases expression |
EXP |
glycidol results in decreased expression of CATIP mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:75,945,960...75,953,618
Ensembl chr 9:75,945,961...75,953,607
|
|
G |
Cav3 |
caveolin 3 |
increases expression |
EXP |
glycidol results in increased expression of CAV3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:145,582,168...145,598,142
Ensembl chr 4:145,582,060...145,598,137
|
|
G |
Cblc |
Cbl proto-oncogene C |
decreases expression |
EXP |
glycidol results in decreased expression of CBLC mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:79,439,975...79,456,755
Ensembl chr 1:79,439,977...79,456,755
|
|
G |
Cbln4 |
cerebellin 4 precursor |
decreases expression |
EXP |
glycidol results in decreased expression of CBLN4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:160,799,587...160,807,143
Ensembl chr 3:160,799,587...160,807,143
|
|
G |
Cbr3 |
carbonyl reductase 3 |
increases expression |
ISO |
glycidol results in increased expression of CBR3 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875
|
|
G |
Ccdc40 |
coiled-coil domain 40 molecular ruler complex subunit |
decreases expression |
EXP |
glycidol results in decreased expression of CCDC40 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:104,486,748...104,527,284
Ensembl chr10:104,486,748...104,527,243
|
|
G |
Ccdc68 |
coiled-coil domain containing 68 |
decreases expression |
EXP |
glycidol results in decreased expression of CCDC68 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:63,541,828...63,584,122
Ensembl chr18:63,541,896...63,584,119
|
|
G |
Ccdc78 |
coiled-coil domain containing 78 |
decreases expression |
EXP |
glycidol results in decreased expression of CCDC78 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:14,808,355...14,812,284
Ensembl chr10:14,807,710...14,812,282
|
|
G |
Ccdc85a |
coiled-coil domain containing 85A |
increases expression |
EXP |
glycidol results in increased expression of CCDC85A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:102,126,574...102,359,207
Ensembl chr14:102,129,029...102,359,058
|
|
G |
Ccdc88b |
coiled-coil domain containing 88B |
increases expression |
EXP |
glycidol results in increased expression of CCDC88B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:204,036,918...204,052,970
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
EXP |
glycidol results in decreased expression of CCL2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
increases expression |
ISO |
glycidol results in increased expression of CCL28 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
increases expression |
EXP |
glycidol results in increased expression of CCL6 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
|
|
G |
Ccn1 |
cellular communication network factor 1 |
decreases expression |
EXP |
glycidol results in decreased expression of CCN1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
EXP |
glycidol results in decreased expression of CCNB1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccrl2 |
C-C motif chemokine receptor like 2 |
decreases expression |
EXP |
glycidol results in decreased expression of CCRL2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664
|
|
G |
Cct8l2 |
chaperonin containing TCP1 subunit 8 like 2 |
increases expression decreases expression |
EXP |
glycidol results in increased expression of CCT8L1 mRNA glycidol results in decreased expression of CCT8L1 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 4:9,605,035...9,606,971
Ensembl chr 4:9,605,000...9,607,208
|
|
G |
Cd37 |
CD37 molecule |
increases expression |
EXP |
glycidol results in increased expression of CD37 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:95,719,171...95,724,662
Ensembl chr 1:95,719,190...95,724,648
|
|
G |
Cd38 |
CD38 molecule |
decreases expression |
EXP |
glycidol results in decreased expression of CD38 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cd44 |
CD44 molecule |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of CD44 mRNA glycidol results in increased expression of CD44 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd5l |
Cd5 molecule-like |
increases expression |
EXP |
glycidol results in increased expression of CD5L mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
|
|
G |
Cd74 |
CD74 molecule |
decreases expression |
EXP |
glycidol results in decreased expression of CD74 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
|
|
G |
Cd83 |
CD83 molecule |
decreases expression |
ISO |
glycidol results in decreased expression of CD83 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
|
|
G |
Cd8a |
CD8 subunit alpha |
decreases expression |
EXP |
glycidol results in decreased expression of CD8A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:103,365,804...103,370,041
Ensembl chr 4:103,365,804...103,370,040
|
|
G |
Cdc42bpg |
CDC42 binding protein kinase gamma |
increases expression |
EXP |
glycidol results in increased expression of CDC42BPG mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:203,608,339...203,628,502
Ensembl chr 1:203,608,574...203,628,502
|
|
G |
Cdca2 |
cell division cycle associated 2 |
decreases expression |
EXP |
glycidol results in decreased expression of CDCA2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
|
|
G |
Cdca3 |
cell division cycle associated 3 |
decreases expression |
EXP |
glycidol results in decreased expression of CDCA3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
|
|
G |
Cdh1 |
cadherin 1 |
affects methylation |
EXP |
glycidol affects the methylation of CDH1 promoter |
CTD |
PMID:27884059 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh19 |
cadherin 19 |
decreases expression |
EXP |
glycidol results in decreased expression of CDH19 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr13:27,935,915...28,047,490
Ensembl chr13:27,936,668...28,019,310
|
|
G |
Cdh3 |
cadherin 3 |
increases expression |
EXP |
glycidol results in increased expression of CDH3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
|
|
G |
Cdhr4 |
cadherin-related family member 4 |
decreases expression |
EXP |
glycidol results in decreased expression of CDHR4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:108,682,594...108,690,358
Ensembl chr 8:108,682,613...108,690,367
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
EXP |
glycidol results in decreased expression of CDK1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
glycidol results in increased expression of CDKN1A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
decreases expression |
EXP |
glycidol results in decreased expression of CDKN1C mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
EXP |
glycidol results in increased expression of CDKN2A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
increases expression |
EXP |
glycidol results in increased expression of CDKN3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
|
|
G |
Cdt1 |
chromatin licensing and DNA replication factor 1 |
increases expression |
EXP |
glycidol results in increased expression of CDT1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
|
|
G |
Ceacam16 |
CEA cell adhesion molecule 16, tectorial membrane component |
increases expression |
EXP |
glycidol results in increased expression of CEACAM16 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:79,514,975...79,524,871
Ensembl chr 1:79,514,975...79,524,871
|
|
G |
Ceacam19 |
CEA cell adhesion molecule 19 |
decreases expression |
EXP |
glycidol results in decreased expression of CEACAM19 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:79,542,107...79,550,927
Ensembl chr 1:79,542,107...79,550,927
|
|
G |
Ceacam4 |
CEA cell adhesion molecule 4 |
decreases expression |
EXP |
glycidol results in decreased expression of CEACAM10 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:80,376,667...80,382,943
Ensembl chr 1:80,376,648...80,382,915
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases expression increases methylation decreases expression |
EXP |
glycidol results in increased expression of CEBPB mRNA glycidol results in increased methylation of CEBPB promoter glycidol results in decreased expression of CEBPB mRNA |
CTD |
PMID:24915197 PMID:33150595 PMID:33150645 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Celf3 |
CUGBP, Elav-like family member 3 |
increases expression |
EXP |
glycidol results in increased expression of CELF3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:182,116,034...182,130,163
Ensembl chr 2:182,116,073...182,130,163
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
EXP |
glycidol results in decreased expression of CENPF mRNA |
CTD |
PMID:24395379 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cenpw |
centromere protein W |
decreases expression |
EXP |
glycidol results in decreased expression of CENPW mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
|
|
G |
Cep72 |
centrosomal protein 72 |
decreases expression |
EXP |
glycidol results in decreased expression of CEP72 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:29,225,312...29,255,294
Ensembl chr 1:29,225,361...29,255,271
|
|
G |
Cep83 |
centrosomal protein 83 |
decreases expression |
EXP |
glycidol results in decreased expression of CEP83 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:29,280,358...29,389,574
Ensembl chr 7:29,280,419...29,389,574
|
|
G |
Cfap141 |
cilia and flagella associated protein 141 |
decreases expression |
EXP |
glycidol results in decreased expression of CFAP141 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:175,507,628...175,510,662
Ensembl chr 2:175,507,628...175,510,662
|
|
G |
Cfap161 |
cilia and flagella associated protein 161 |
increases expression |
EXP |
glycidol results in increased expression of CFAP161 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:137,743,783...137,768,685
Ensembl chr 1:137,743,784...137,768,730
|
|
G |
Cfap206 |
cilia and flagella associated protein 206 |
decreases expression |
EXP |
glycidol results in decreased expression of CFAP206 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:49,254,399...49,299,145
Ensembl chr 5:49,254,408...49,299,090
|
|
G |
Cfap210 |
cilia and flagella associated protein 210 |
decreases expression |
EXP |
glycidol results in decreased expression of CFAP210 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:54,520,455...54,554,677
Ensembl chr 3:54,520,458...54,554,607
|
|
G |
Cfap300 |
cilia and flagella associated protein 300 |
increases expression |
EXP |
glycidol results in increased expression of CFAP300 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807
|
|
G |
Cfap43 |
cilia and flagella associated protein 43 |
decreases expression |
EXP |
glycidol results in decreased expression of CFAP43 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:246,625,259...246,712,438
Ensembl chr 1:246,625,262...246,712,443
|
|
G |
Cfap95 |
cilia and flagella associated protein 95 |
increases expression |
EXP |
glycidol results in increased expression of CFAP95 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:221,123,786...221,242,963
Ensembl chr 1:221,131,813...221,242,963
|
|
G |
Cftr |
CF transmembrane conductance regulator |
decreases expression |
EXP |
glycidol results in decreased expression of CFTR mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
|
|
G |
Ch25h |
cholesterol 25-hydroxylase |
decreases expression |
EXP |
glycidol results in decreased expression of CH25H mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:232,014,877...232,016,195
Ensembl chr 1:232,014,880...232,016,195
|
|
G |
Chmp4c |
charged multivesicular body protein 4C |
decreases expression |
EXP |
glycidol results in decreased expression of CHMP4C mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:91,391,729...91,428,652
Ensembl chr 2:91,388,530...91,428,668
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3 |
decreases expression |
EXP |
glycidol results in decreased expression of CHRM3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
decreases expression |
EXP |
glycidol results in decreased expression of CIDEA mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:60,894,917...60,920,485
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Cilp |
cartilage intermediate layer protein |
decreases expression |
EXP |
glycidol results in decreased expression of CILP mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:65,777,281...65,792,251
Ensembl chr 8:65,777,281...65,792,251
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
decreases expression |
EXP |
glycidol results in decreased expression of CISH mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
decreases expression |
EXP |
glycidol results in decreased expression of CITED4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:134,246,936...134,247,827
Ensembl chr 5:134,246,682...134,248,135
|
|
G |
Ckap2 |
cytoskeleton associated protein 2 |
decreases expression |
EXP |
glycidol results in decreased expression of CKAP2 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
increases expression |
EXP |
glycidol results in increased expression of CLCF1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Cldn1 |
claudin 1 |
affects expression |
EXP |
glycidol affects the expression of CLDN1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cldn19 |
claudin 19 |
decreases expression |
EXP |
glycidol results in decreased expression of CLDN19 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:132,862,939...132,870,364
Ensembl chr 5:132,863,267...132,868,227
|
|
G |
Cldn2 |
claudin 2 |
increases expression |
EXP |
glycidol results in increased expression of CLDN2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cldn3 |
claudin 3 |
increases expression |
EXP |
glycidol results in increased expression of CLDN3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
|
|
G |
Clec2d2 |
C-type lectin domain family 2 member D2 |
increases expression |
EXP |
glycidol results in increased expression of CLEC2D2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:162,059,007...162,071,088
Ensembl chr 4:162,059,008...162,071,088
|
|
G |
Clic6 |
chloride intracellular channel 6 |
increases expression |
EXP |
glycidol results in increased expression of CLIC6 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr11:31,737,813...31,780,360
Ensembl chr11:31,737,813...31,780,061
|
|
G |
Clint1 |
clathrin interactor 1 |
decreases expression |
EXP |
glycidol results in decreased expression of CLINT1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:30,298,618...30,353,185
Ensembl chr10:30,298,704...30,353,063
|
|
G |
Cltrn |
collectrin, amino acid transport regulator |
increases expression |
EXP |
glycidol results in increased expression of CLTRN mRNA |
CTD |
PMID:24395379 |
|
NCBI chr X:30,361,967...30,395,264
Ensembl chr X:30,361,967...30,395,349
|
|
G |
Clu |
clusterin |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in increased expression of CLU mRNA |
CTD |
PMID:33187795 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Clxn |
calaxin |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of CLXN mRNA glycidol results in increased expression of CLXN mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr11:85,977,231...85,996,561
Ensembl chr11:85,983,304...85,996,538
|
|
G |
Cnmd |
chondromodulin |
decreases expression |
EXP |
glycidol results in decreased expression of CNMD mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297
|
|
G |
Cntd1 |
cyclin N-terminal domain containing 1 |
decreases expression |
EXP |
glycidol results in decreased expression of CNTD1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:86,221,430...86,231,812
|
|
G |
Cntf |
ciliary neurotrophic factor |
decreases expression |
EXP |
glycidol results in decreased expression of CNTF mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:209,887,854...209,889,877
Ensembl chr 1:209,887,854...209,889,877
|
|
G |
Cntn3 |
contactin 3 |
increases expression |
EXP |
glycidol results in increased expression of CNTN3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:134,842,266...135,125,613
|
|
G |
Col11a1 |
collagen type XI alpha 1 chain |
affects expression |
EXP |
glycidol affects the expression of COL11A1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:201,820,715...202,013,853
Ensembl chr 2:201,820,715...202,013,853
|
|
G |
Col27a1 |
collagen type XXVII alpha 1 chain |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of COL27A1 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 5:76,647,302...76,765,989
Ensembl chr 5:76,647,429...76,765,174
|
|
G |
Col8a1 |
collagen type VIII alpha 1 chain |
increases expression |
EXP |
glycidol results in increased expression of COL8A1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
|
|
G |
Col8a2 |
collagen type VIII alpha 2 chain |
increases expression |
EXP |
glycidol results in increased expression of COL8A2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:138,586,201...138,613,627
Ensembl chr 5:138,585,999...138,612,850
|
|
G |
Colq |
collagen like tail subunit of asymmetric acetylcholinesterase |
affects expression |
EXP |
glycidol affects the expression of COLQ mRNA |
CTD |
PMID:24395379 |
|
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
|
|
G |
Comt |
catechol-O-methyltransferase |
increases expression |
EXP |
glycidol results in increased expression of COMT mRNA |
CTD |
PMID:24915197 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Copz2 |
COPI coat complex subunit zeta 2 |
increases expression |
EXP |
glycidol results in increased expression of COPZ2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:81,832,441...81,845,514
Ensembl chr10:81,832,418...81,845,514
|
|
G |
Coro7 |
coronin 7 |
increases expression |
EXP |
glycidol results in increased expression of CORO7 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:10,880,299...10,941,001
Ensembl chr10:10,885,196...10,941,001
|
|
G |
Cort |
cortistatin |
decreases expression |
EXP |
glycidol results in decreased expression of CORT mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:159,560,591...159,562,032
|
|
G |
Crb3 |
crumbs cell polarity complex component 3 |
increases expression |
EXP |
glycidol results in increased expression of CRB3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:1,898,531...1,903,860
Ensembl chr 9:1,896,623...1,903,859
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of CREB1 mRNA glycidol results in increased methylation of CREB1 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crem |
cAMP responsive element modulator |
increases expression |
EXP |
glycidol results in increased expression of CREM mRNA |
CTD |
PMID:24395379 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crh |
corticotropin releasing hormone |
decreases expression |
EXP |
glycidol results in decreased expression of CRH mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:102,143,055...102,144,919
|
|
G |
Cryab |
crystallin, alpha B |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in increased expression of CRYAB mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
increases expression |
EXP |
glycidol results in increased expression of CSAD mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
|
|
G |
Cthrc1 |
collagen triple helix repeat containing 1 |
increases expression |
EXP |
glycidol results in increased expression of CTHRC1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:70,122,474...70,132,756
Ensembl chr 7:70,122,474...70,132,756
|
|
G |
Ctnna3 |
catenin alpha 3 |
decreases expression |
EXP |
glycidol results in decreased expression of CTNNA3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr20:23,614,469...25,200,026
Ensembl chr20:23,623,560...25,199,978
|
|
G |
Ctxn3 |
cortexin 3 |
decreases expression |
EXP |
glycidol results in decreased expression of CTXN3 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr18:50,930,244...50,940,642
Ensembl chr18:50,930,235...50,940,641
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of CX3CR1 mRNA glycidol results in increased methylation of CX3CR1 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 8:119,785,726...119,799,431
Ensembl chr 8:119,782,595...119,800,014
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
increases expression |
EXP |
glycidol results in increased expression of CXCL12 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of CXCR4 promoter glycidol results in decreased expression of CXCR4 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of CYP4B1 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
EXP |
glycidol results in decreased expression of CYP51 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Dact2 |
dishevelled-binding antagonist of beta-catenin 2 |
decreases expression |
EXP |
glycidol results in decreased expression of DACT2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:55,181,023...55,191,026
Ensembl chr 1:55,181,024...55,191,096
|
|
G |
Dao |
D-amino-acid oxidase |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of DAO promoter glycidol results in decreased expression of DAO mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr12:42,592,342...42,613,046
Ensembl chr12:42,592,343...42,612,741
|
|
G |
Dapk3 |
death-associated protein kinase 3 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of DAPK3 mRNA glycidol results in increased methylation of DAPK3 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 7:8,524,182...8,532,552
Ensembl chr 7:8,524,183...8,532,558
|
|
G |
Dbn1 |
drebrin 1 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of DBN1 promoter glycidol results in decreased expression of DBN1 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984
|
|
G |
Dclk1 |
doublecortin-like kinase 1 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of DCLK1 mRNA glycidol results in increased methylation of DCLK1 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956
|
|
G |
Dclk3 |
doublecortin-like kinase 3 |
decreases expression |
EXP |
glycidol results in decreased expression of DCLK3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:111,401,358...111,453,999
|
|
G |
Dcst1 |
DC-STAMP domain containing 1 |
decreases expression |
EXP |
glycidol results in decreased expression of DCST1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:174,765,203...174,784,023
Ensembl chr 2:174,765,350...174,781,806
|
|
G |
Dct |
dopachrome tautomerase |
increases expression |
EXP |
glycidol results in increased expression of DCT mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
decreases expression |
EXP |
glycidol results in decreased expression of DDIT4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
increases expression |
EXP |
glycidol results in increased expression of DDIT4L mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
|
|
G |
Ddx20 |
DEAD-box helicase 20 |
increases expression |
EXP |
glycidol results in increased expression of DDX20 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:193,158,761...193,168,484
Ensembl chr 2:193,158,823...193,166,774
|
|
G |
Ddx43 |
DEAD-box helicase 43 |
decreases expression |
EXP |
glycidol results in decreased expression of DDX43 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:79,255,001...79,284,468
Ensembl chr 8:79,255,655...79,284,453
|
|
G |
Depp1 |
DEPP autophagy regulator 1 |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in increased expression of DEPP1 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
|
|
G |
Dgkg |
diacylglycerol kinase, gamma |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of DGKG mRNA glycidol results in increased methylation of DGKG promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr11:78,384,212...78,579,158
Ensembl chr11:78,384,458...78,577,212
|
|
G |
Dhrs7c |
dehydrogenase/reductase 7C |
decreases expression |
EXP |
glycidol results in decreased expression of DHRS7C mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:52,495,262...52,513,338
Ensembl chr10:52,495,262...52,513,338
|
|
G |
Dhx9 |
DExH-box helicase 9 |
decreases expression |
EXP |
glycidol results in decreased expression of DHX9 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr13:65,602,322...65,639,098
Ensembl chr13:65,602,323...65,639,069
|
|
G |
Dkkl1 |
dickkopf like acrosomal protein 1 |
increases expression |
EXP |
glycidol results in increased expression of DKKL1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:95,694,010...95,699,259
Ensembl chr 1:95,694,010...95,699,259
|
|
G |
Dlc1 |
DLC1 Rho GTPase activating protein |
increases expression |
EXP |
glycidol results in increased expression of DLC1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr16:55,246,716...55,671,441
Ensembl chr16:55,291,584...55,671,439
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
increases expression |
EXP |
glycidol results in increased expression of DLK1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of DLL1 mRNA glycidol results in increased methylation of DLL1 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dll3 |
delta like canonical Notch ligand 3 |
decreases expression |
EXP |
glycidol results in decreased expression of DLL3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:83,562,011...83,570,008
Ensembl chr 1:83,562,014...83,569,750
|
|
G |
Dlx2 |
distal-less homeobox 2 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of DLX2 mRNA glycidol results in increased methylation of DLX2 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 3:56,370,238...56,373,581
Ensembl chr 3:56,370,483...56,373,597
|
|
G |
Dmbx1 |
diencephalon/mesencephalon homeobox 1 |
increases expression |
EXP |
glycidol results in increased expression of DMBX1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:129,394,221...129,403,040
Ensembl chr 5:129,394,221...129,403,040
|
|
G |
Dmrtc1c1 |
DMRT-like family C1c1 |
decreases expression |
EXP |
glycidol results in decreased expression of DMRTC1B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:67,896,973...67,904,182
Ensembl chr X:67,896,974...67,904,182
|
|
G |
Dnah1 |
dynein, axonemal, heavy chain 1 |
increases expression |
EXP |
glycidol results in increased expression of DNAH1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr16:6,455,514...6,517,103
Ensembl chr16:6,456,002...6,518,350
|
|
G |
Dnah12 |
dynein, axonemal, heavy chain 12 |
increases expression |
EXP |
glycidol results in increased expression of DNAH12 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr16:1,936,354...2,092,663
Ensembl chr16:1,937,817...2,092,664
|
|
G |
Dnai2 |
dynein, axonemal, intermediate chain 2 |
decreases expression |
EXP |
glycidol results in decreased expression of DNAI2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:99,759,966...99,793,379
Ensembl chr10:99,759,966...99,793,378
|
|
G |
Dnase1 |
deoxyribonuclease 1 |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of DNASE1 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869
|
|
G |
Dnm1l |
dynamin 1-like |
decreases expression |
EXP |
glycidol results in decreased expression of DNM1L mRNA |
CTD |
PMID:24395379 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Dok3 |
docking protein 3 |
increases expression |
EXP |
glycidol results in increased expression of DOK3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
decreases expression |
EXP |
glycidol results in decreased expression of DPYD mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpysl4 |
dihydropyrimidinase-like 4 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of DPYSL4 promoter glycidol results in decreased expression of DPYSL4 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
|
|
G |
Drc1 |
dynein regulatory complex subunit 1 |
decreases expression |
EXP |
glycidol results in decreased expression of DRC1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:26,025,004...26,059,438
Ensembl chr 6:26,025,005...26,059,414
|
|
G |
Drc12 |
dynein regulatory complex subunit 12 homolog |
decreases expression |
EXP |
glycidol results in decreased expression of CCDC153 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:44,576,528...44,584,345
Ensembl chr 8:44,577,836...44,584,338
|
|
G |
Dsg2 |
desmoglein 2 |
decreases expression |
EXP |
glycidol results in decreased expression of DSG2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:11,846,207...11,904,630
Ensembl chr18:11,846,183...11,904,156
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
decreases expression |
EXP |
glycidol results in decreased expression of DUSP1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp16 |
dual specificity phosphatase 16 |
decreases expression |
EXP |
glycidol results in decreased expression of DUSP16 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:167,546,780...167,630,173
Ensembl chr 4:167,548,155...167,629,980
|
|
G |
Dusp19 |
dual specificity phosphatase 19 |
increases expression |
EXP |
glycidol results in increased expression of DUSP19 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:65,538,424...65,554,465
Ensembl chr 3:65,538,420...65,553,534
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
decreases expression |
EXP |
glycidol results in decreased expression of DUSP8 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:197,167,392...197,184,285
Ensembl chr 1:197,169,422...197,182,921
|
|
G |
Dynlrb2 |
dynein light chain roadblock-type 2 |
decreases expression |
EXP |
glycidol results in decreased expression of DYNLRB2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr19:44,520,134...44,531,384
Ensembl chr19:44,520,134...44,531,387
|
|
G |
Eaf1 |
ELL associated factor 1 |
increases expression |
EXP |
glycidol results in increased expression of EAF1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr16:6,698,322...6,713,071
Ensembl chr16:6,698,322...6,713,071
|
|
G |
Ece1 |
endothelin converting enzyme 1 |
affects expression |
EXP |
glycidol affects the expression of ECE1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371
|
|
G |
Ecm1 |
extracellular matrix protein 1 |
decreases expression |
ISO |
glycidol results in decreased expression of ECM1 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
|
|
G |
Ect2 |
epithelial cell transforming 2 |
decreases expression |
EXP |
glycidol results in decreased expression of ECT2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
|
|
G |
Eda2r |
ectodysplasin A2 receptor |
increases expression |
EXP |
glycidol results in increased expression of EDA2R mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:62,224,763...62,269,333
Ensembl chr X:62,228,229...62,269,268
|
|
G |
Edem3 |
ER degradation enhancing alpha-mannosidase like protein 3 |
increases expression |
EXP |
glycidol results in increased expression of EDEM3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:63,858,282...63,920,538
Ensembl chr13:63,858,716...63,920,523
|
|
G |
Edn1 |
endothelin 1 |
decreases expression |
EXP |
glycidol results in decreased expression of EDN1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Efhc1 |
EF-hand domain containing 1 |
increases expression |
EXP |
glycidol results in increased expression of EFHC1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283
|
|
G |
Efhc2 |
EF-hand domain containing 2 |
increases expression |
EXP |
glycidol results in increased expression of EFHC2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:5,360,499...5,564,004
Ensembl chr X:5,360,617...5,560,970
|
|
G |
Efnb3 |
ephrin B3 |
increases expression |
EXP |
glycidol results in increased expression of EFNB3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:54,274,506...54,281,951
Ensembl chr10:54,274,506...54,280,471
|
|
G |
Egf |
epidermal growth factor |
multiple interactions decreases expression increases methylation |
ISO EXP |
[alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of EGF mRNA glycidol results in decreased expression of EGF mRNA glycidol results in increased methylation of EGF promoter |
CTD |
PMID:33150595 PMID:33150645 PMID:33187795 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egr4 |
early growth response 4 |
decreases expression |
EXP |
glycidol results in decreased expression of EGR4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328
|
|
G |
Eid3 |
EP300 interacting inhibitor of differentiation 3 |
increases expression |
EXP |
glycidol results in increased expression of EID3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:20,860,073...20,861,395
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
decreases expression |
EXP |
glycidol results in decreased expression of ELMO1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788
|
|
G |
Emcn |
endomucin |
decreases expression |
EXP |
glycidol results in decreased expression of EMCN mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:225,891,100...225,970,932
Ensembl chr 2:225,891,100...225,970,929
|
|
G |
Emid1 |
EMI domain containing 1 |
decreases expression |
EXP |
glycidol results in decreased expression of EMID1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:80,000,486...80,043,561
Ensembl chr14:80,000,486...80,043,620
|
|
G |
Eno4 |
enolase 4 |
increases expression |
EXP |
glycidol results in increased expression of ENO4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:258,096,406...258,119,811
Ensembl chr 1:258,096,432...258,128,984
|
|
G |
Epcam |
epithelial cell adhesion molecule |
increases expression |
EXP |
glycidol results in increased expression of EPCAM mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Epha5 |
EPH receptor A5 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of EPHA5 mRNA glycidol results in increased methylation of EPHA5 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr14:23,653,393...24,020,129
Ensembl chr14:23,653,393...24,017,317
|
|
G |
Epn3 |
epsin 3 |
increases expression |
EXP |
glycidol results in increased expression of EPN3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:79,438,978...79,449,516
Ensembl chr10:79,438,978...79,447,356
|
|
G |
Eps8l2 |
EPS8-like 2 |
increases expression |
EXP |
glycidol results in increased expression of EPS8L2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:196,446,260...196,471,544
Ensembl chr 1:196,446,287...196,471,541
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
decreases expression |
EXP |
glycidol results in decreased expression of ERBB3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
|
|
G |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
decreases expression |
EXP |
glycidol results in decreased expression of ERC1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:152,763,664...153,055,724
Ensembl chr 4:152,767,419...153,055,639
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
increases expression |
EXP |
glycidol results in increased expression of ERCC6 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Erich2 |
glutamate-rich 2 |
increases expression |
EXP |
glycidol results in increased expression of ERICH2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:55,310,993...55,347,701
Ensembl chr 3:55,310,993...55,347,184
|
|
G |
Ermn |
ermin |
decreases expression |
EXP |
glycidol results in decreased expression of ERMN mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:42,628,160...42,633,816
Ensembl chr 3:42,626,309...42,633,744
|
|
G |
Etfbkmt |
electron transfer flavoprotein subunit beta lysine methyltransferase |
decreases expression |
EXP |
glycidol results in decreased expression of ETFBKMT mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:182,140,492...182,204,635
Ensembl chr 4:182,140,559...182,150,305
|
|
G |
Exoc3l1 |
exocyst complex component 3-like 1 |
increases expression |
EXP |
glycidol results in increased expression of EXOC3L1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr19:33,166,836...33,174,371
Ensembl chr19:33,166,837...33,172,486
|
|
G |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
decreases expression |
EXP |
glycidol results in decreased expression of EYA2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793
|
|
G |
F5 |
coagulation factor V |
increases expression |
EXP |
glycidol results in increased expression of F5 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr13:76,513,509...76,583,106
Ensembl chr13:76,513,255...76,582,317
|
|
G |
Fam161a |
FAM161 centrosomal protein A |
increases expression |
EXP |
glycidol results in increased expression of FAM161A mRNA |
CTD |
PMID:24395379 |
|
NCBI chr14:97,009,449...97,027,865
Ensembl chr14:97,009,491...97,028,588
|
|
G |
Fam169b |
family with sequence similarity 169, member B |
increases expression |
EXP |
glycidol results in increased expression of FAM169B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:121,878,670...121,968,272
Ensembl chr 1:121,878,713...121,958,470
|
|
G |
Fam193a |
family with sequence similarity 193, member A |
increases expression |
EXP |
glycidol results in increased expression of FAM193A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:76,250,103...76,382,525
Ensembl chr14:76,256,161...76,382,514
|
|
G |
Fam227a |
family with sequence similarity 227, member A |
increases expression |
EXP |
glycidol results in increased expression of FAM227A mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:111,174,362...111,216,513
Ensembl chr 7:111,174,362...111,216,483
|
|
G |
Fam24b |
family with sequence similarity 24 member B |
increases expression |
EXP |
glycidol results in increased expression of FAM24B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:186,112,544...186,115,957
Ensembl chr 1:186,112,551...186,115,899
|
|
G |
Fam43a |
family with sequence similarity 43, member A |
increases expression |
EXP |
glycidol results in increased expression of FAM43A mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401
|
|
G |
Fam83d |
family with sequence similarity 83, member D |
decreases expression |
EXP |
glycidol results in decreased expression of FAM83D mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
glycidol results in increased expression of FASLG mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fat4 |
FAT atypical cadherin 4 |
decreases expression |
EXP |
glycidol results in decreased expression of FAT4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:121,927,266...122,056,700
Ensembl chr 2:121,927,942...122,056,707
|
|
G |
Fbxo4 |
F-box protein 4 |
increases expression |
EXP |
glycidol results in increased expression of FBXO4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:53,174,798...53,187,792
Ensembl chr 2:53,174,798...53,187,792
|
|
G |
Fer |
FER tyrosine kinase |
decreases expression |
EXP |
glycidol results in decreased expression of FER mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:103,520,452...103,827,364
Ensembl chr 9:103,520,493...103,821,451
|
|
G |
Fermt1 |
FERM domain containing kindlin 1 |
increases expression |
EXP |
glycidol results in increased expression of FERMT1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:120,171,301...120,213,555
Ensembl chr 3:120,171,561...120,213,555
|
|
G |
Fgf13 |
fibroblast growth factor 13 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of FGF13 promoter glycidol results in decreased expression of FGF13 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr X:137,276,498...137,800,056
Ensembl chr X:137,276,511...137,800,391
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of FGF2 promoter glycidol results in decreased expression of FGF2 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fibin |
fin bud initiation factor homolog |
decreases expression |
EXP |
glycidol results in decreased expression of FIBIN mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
increases expression |
EXP |
glycidol results in increased expression of FKBP5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
decreases expression |
EXP |
glycidol results in decreased expression of FMO1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
|
|
G |
Fmod |
fibromodulin |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of FMOD mRNA glycidol results in increased expression of FMOD mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr13:45,493,517...45,504,134
Ensembl chr13:45,493,517...45,504,133
|
|
G |
Folr1 |
folate receptor alpha |
increases expression |
EXP |
glycidol results in increased expression of FOLR1 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
glycidol results in decreased expression of FOS mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
decreases expression |
EXP |
glycidol results in decreased expression of FOSL2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Frzb |
frizzled-related protein |
increases expression |
EXP |
glycidol results in increased expression of FRZB mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
|
|
G |
Fscn2 |
fascin actin-bundling protein 2, retinal |
increases expression |
EXP |
glycidol results in increased expression of FSCN2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:105,634,783...105,641,322
Ensembl chr10:105,634,783...105,641,322
|
|
G |
Fsip1 |
fibrous sheath interacting protein 1 |
increases expression |
EXP |
glycidol results in increased expression of FSIP1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:105,074,584...105,217,180
Ensembl chr 3:105,068,543...105,217,167
|
|
G |
Fstl1 |
follistatin-like 1 |
decreases expression |
EXP |
glycidol results in decreased expression of FSTL1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
|
|
G |
Fstl4 |
follistatin-like 4 |
increases expression |
EXP |
glycidol results in increased expression of FSTL4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:36,911,422...37,344,545
Ensembl chr10:36,911,420...37,338,588
|
|
G |
Fut4 |
fucosyltransferase 4 |
increases expression |
EXP |
glycidol results in increased expression of FUT4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:11,586,721...11,590,682
Ensembl chr 8:11,586,721...11,590,682
|
|
G |
Fxyd6 |
FXYD domain-containing ion transport regulator 6 |
increases expression |
EXP |
glycidol results in increased expression of FXYD6 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:45,679,054...45,705,958
Ensembl chr 8:45,678,885...45,705,958
|
|
G |
Fzd6 |
frizzled class receptor 6 |
increases expression |
EXP |
glycidol results in increased expression of FZD6 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:70,055,012...70,086,781
Ensembl chr 7:70,055,068...70,086,776
|
|
G |
G2e3 |
G2/M-phase specific E3 ubiquitin protein ligase |
increases expression |
EXP |
glycidol results in increased expression of G2E3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:68,763,847...68,795,305
Ensembl chr 6:68,764,185...68,793,924
|
|
G |
Gabrb1 |
gamma-aminobutyric acid type A receptor subunit beta1 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of GABRB1 promoter glycidol results in decreased expression of GABRB1 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr14:36,068,725...36,548,946
Ensembl chr14:36,080,393...36,548,948
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
decreases expression |
EXP |
glycidol results in decreased expression of GADD45G mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gal |
galanin and GMAP prepropeptide |
increases expression |
EXP |
glycidol results in increased expression of GAL mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:200,650,439...200,655,302
Ensembl chr 1:200,650,439...200,654,959
|
|
G |
Galnt10 |
polypeptide N-acetylgalactosaminyltransferase 10 |
increases expression |
EXP |
glycidol results in increased expression of GALNT10 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:41,821,216...41,967,618
Ensembl chr10:41,820,158...41,967,013
|
|
G |
Galnt6 |
polypeptide N-acetylgalactosaminyltransferase 6 |
decreases expression |
EXP |
glycidol results in decreased expression of GALNT6 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:131,789,836...131,828,077
Ensembl chr 7:131,789,839...131,819,661
|
|
G |
Gamt |
guanidinoacetate N-methyltransferase |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of GAMT mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
|
|
G |
Gask1b |
golgi associated kinase 1B |
decreases expression |
EXP |
glycidol results in decreased expression of GASK1B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
|
|
G |
Gcnt2 |
glucosaminyl (N-acetyl) transferase 2 |
decreases expression |
EXP |
glycidol results in decreased expression of GCNT2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:23,796,859...23,901,625
Ensembl chr17:23,796,859...23,901,611
|
|
G |
Gfap |
glial fibrillary acidic protein |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of GFAP mRNA glycidol results in increased expression of GFAP mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gfm2 |
GTP dependent ribosome recycling factor mitochondrial 2 |
decreases expression |
EXP |
glycidol results in decreased expression of GFM2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:28,449,452...28,488,200
Ensembl chr 2:28,449,517...28,488,197
|
|
G |
Ghrh |
growth hormone releasing hormone |
increases expression |
EXP |
glycidol results in increased expression of GHRH mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:145,992,762...146,012,528
Ensembl chr 3:145,992,763...146,011,889
|
|
G |
Gimap7 |
GTPase, IMAP family member 7 |
increases expression |
EXP |
glycidol results in increased expression of GIMAP7 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:77,670,522...77,674,692
Ensembl chr 4:77,670,367...77,675,272
|
|
G |
Ginm1 |
glycosylated integral membrane protein 1 |
decreases expression |
EXP |
glycidol results in decreased expression of GINM1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:2,246,384...2,262,260
Ensembl chr 1:2,246,394...2,262,217
|
|
G |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
decreases expression |
EXP |
glycidol results in decreased expression of GIPC2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
|
|
G |
Gipr |
gastric inhibitory polypeptide receptor |
increases expression |
EXP |
glycidol results in increased expression of GIPR mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:78,804,287...78,814,462
Ensembl chr 1:78,805,593...78,814,462
|
|
G |
Glb1l |
galactosidase, beta 1-like |
increases expression |
EXP |
glycidol results in increased expression of GLB1L mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:76,693,325...76,705,548
Ensembl chr 9:76,695,173...76,705,510
|
|
G |
Glipr1 |
GLI pathogenesis-related 1 |
decreases expression |
EXP |
glycidol results in decreased expression of GLIPR1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429
|
|
G |
Gng8 |
G protein subunit gamma 8 |
decreases expression |
EXP |
glycidol results in decreased expression of GNG8 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:77,564,512...77,568,371
Ensembl chr 1:77,564,515...77,568,371
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
decreases expression |
EXP |
glycidol results in decreased expression of GPAM mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
|
|
G |
Gpatch4 |
G patch domain containing 4 |
increases expression |
EXP |
glycidol results in increased expression of GPATCH4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:173,499,700...173,520,346
Ensembl chr 2:173,509,897...173,518,684
|
|
G |
Gpc2 |
glypican 2 |
decreases expression |
EXP |
glycidol results in decreased expression of GPC2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr12:17,277,875...17,284,297
Ensembl chr12:17,277,875...17,284,208
|
|
G |
Gpc3 |
glypican 3 |
increases expression |
EXP |
glycidol results in increased expression of GPC3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
|
|
G |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 |
decreases expression |
EXP |
glycidol results in decreased expression of GPD1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
|
|
G |
Gpm6b |
glycoprotein m6b |
decreases expression |
EXP |
glycidol results in decreased expression of GPM6B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:28,057,788...28,204,409
Ensembl chr X:28,059,450...28,204,211
|
|
G |
Gpr160 |
G protein-coupled receptor 160 |
increases expression |
EXP |
glycidol results in increased expression of GPR160 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:112,483,364...112,563,072
Ensembl chr 2:112,484,935...112,563,148
|
|
G |
Gpr161 |
G protein-coupled receptor 161 |
increases expression |
EXP |
glycidol results in increased expression of GPR161 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:77,578,257...77,623,661
Ensembl chr13:77,577,739...77,619,613
|
|
G |
Gpr171 |
G protein-coupled receptor 171 |
decreases expression |
EXP |
glycidol results in decreased expression of GPR171 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:143,360,402...143,365,494
Ensembl chr 2:143,359,564...143,366,698
|
|
G |
Gpr18 |
G protein-coupled receptor 18 |
increases expression |
EXP |
glycidol results in increased expression of GPR18 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470
|
|
G |
Gpr6 |
G protein-coupled receptor 6 |
decreases expression |
EXP |
glycidol results in decreased expression of GPR6 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:44,489,853...44,492,624
Ensembl chr20:44,489,853...44,492,624
|
|
G |
Gprc5a |
G protein-coupled receptor, class C, group 5, member A |
increases expression |
EXP |
glycidol results in increased expression of GPRC5A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
|
|
G |
Gprc5c |
G protein-coupled receptor, class C, group 5, member C |
increases expression |
EXP |
glycidol results in increased expression of GPRC5C mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:99,886,900...99,908,928
Ensembl chr10:99,887,077...99,908,926
|
|
G |
Grb10 |
growth factor receptor bound protein 10 |
increases expression |
EXP |
glycidol results in increased expression of GRB10 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:86,495,051...86,602,800
Ensembl chr14:86,495,054...86,602,806
|
|
G |
Grik3 |
glutamate ionotropic receptor kainate type subunit 3 |
increases expression |
EXP |
glycidol results in increased expression of GRIK3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:137,767,865...137,989,617
Ensembl chr 5:137,767,865...137,984,307
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of GRIN2B mRNA glycidol results in increased methylation of GRIN2B promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
|
|
G |
Grm4 |
glutamate metabotropic receptor 4 |
decreases expression |
EXP |
glycidol results in decreased expression of GRM4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:5,484,172...5,572,821
Ensembl chr20:5,481,124...5,572,821
|
|
G |
Gsdmd |
gasdermin D |
increases cleavage |
EXP |
glycidol results in increased cleavage of GSDMD protein |
CTD |
PMID:33187795 |
|
NCBI chr 7:107,542,489...107,547,051
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsdmdl1 |
gasdermin D like 1 |
decreases expression |
EXP |
glycidol results in decreased expression of GSDMDL1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:95,620,052...95,630,546
Ensembl chr 7:95,620,061...95,630,532
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of GSK3B promoter glycidol results in decreased expression of GSK3B mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Guca1b |
guanylate cyclase activator 1B |
decreases expression |
EXP |
glycidol results in decreased expression of GUCA1B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:13,599,619...13,607,455
Ensembl chr 9:13,599,619...13,607,455
|
|
G |
Gys2 |
glycogen synthase 2 |
increases expression |
EXP |
glycidol results in increased expression of GYS2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
|
|
G |
H1f5 |
H1.5 linker histone, cluster member |
decreases expression |
EXP |
glycidol results in decreased expression of H1F5 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr17:42,726,132...42,727,162
Ensembl chr17:42,726,127...42,769,160
|
|
G |
H1f8 |
H1.8 linker histone |
increases expression |
EXP |
glycidol results in increased expression of H1F8 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:148,993,133...148,998,254
Ensembl chr 4:148,993,133...148,998,254
|
|
G |
H2bc8 |
H2B clustered histone 8 |
decreases expression |
EXP |
glycidol results in decreased expression of H2BC8 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr17:42,708,658...42,709,408
|
|
G |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
increases expression |
EXP |
glycidol results in increased expression of H6PD mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
|
|
G |
Has2 |
hyaluronan synthase 2 |
decreases expression |
EXP |
glycidol results in decreased expression of HAS2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions increases expression |
ISO |
alpha-Chlorohydrin promotes the reaction [glycidol results in increased expression of HAVCR1 protein]; glycidol promotes the reaction [alpha-Chlorohydrin results in increased expression of HAVCR1 protein] glycidol results in increased expression of HAVCR1 mRNA; glycidol results in increased expression of HAVCR1 protein |
CTD |
PMID:33187795 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hcst |
hematopoietic cell signal transducer |
decreases expression |
ISO |
glycidol results in decreased expression of HCST mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 1:85,676,976...85,679,083
Ensembl chr 1:85,676,979...85,679,012
|
|
G |
Hdac9 |
histone deacetylase 9 |
decreases expression |
EXP |
glycidol results in decreased expression of HDAC9 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
|
|
G |
Herc3 |
HECT and RLD domain containing E3 ubiquitin protein ligase 3 |
decreases expression |
EXP |
glycidol results in decreased expression of HERC3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:87,952,202...88,042,492
Ensembl chr 4:87,952,274...88,042,488
|
|
G |
Hes5 |
hes family bHLH transcription factor 5 |
increases expression increases methylation decreases expression |
EXP |
glycidol results in increased expression of HES5 mRNA glycidol results in increased methylation of HES5 promoter glycidol results in decreased expression of HES5 mRNA |
CTD |
PMID:24915197 PMID:33150595 PMID:33150645 |
|
NCBI chr 5:165,522,138...165,523,684
Ensembl chr 5:165,522,234...165,523,001
|
|
G |
Hist1h2bq |
histone cluster 1 H2B family member Q |
decreases expression |
EXP |
glycidol results in decreased expression of HIST1H2BQ mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
|
|
G |
Hlcs |
holocarboxylase synthetase |
decreases expression |
EXP |
glycidol results in decreased expression of HLCS mRNA |
CTD |
PMID:24915197 |
|
NCBI chr11:33,455,806...33,635,197
Ensembl chr11:33,455,809...33,624,222
|
|
G |
Hmgb2 |
high mobility group box 2 |
decreases expression |
EXP |
glycidol results in decreased expression of HMGB2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
decreases expression |
EXP |
glycidol results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmox2-ps1 |
heme oxygenase (decycling) 2, pseudogene 1 |
increases expression |
EXP |
glycidol results in increased expression of HMOX2-PS1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:200,299,951...200,302,161
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases expression |
EXP |
glycidol results in decreased expression of HNRNPA1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
|
|
G |
Homer1 |
homer scaffold protein 1 |
increases expression |
EXP |
glycidol results in increased expression of HOMER1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:24,542,777...24,645,715
Ensembl chr 2:24,543,093...24,644,785
|
|
G |
Hoxd3 |
homeo box D3 |
decreases expression |
EXP |
glycidol results in decreased expression of HOXD3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:59,638,708...59,650,282
Ensembl chr 3:59,638,708...59,650,282
|
|
G |
Hoxd4 |
homeo box D4 |
increases expression |
EXP |
glycidol results in increased expression of HOXD4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:59,614,464...59,634,042
Ensembl chr 3:59,614,464...59,631,528
|
|
G |
Hpd |
4-hydroxyphenylpyruvate dioxygenase |
decreases expression |
EXP |
glycidol results in decreased expression of HPD mRNA |
CTD |
PMID:24915197 |
|
NCBI chr12:33,381,397...33,392,750
Ensembl chr12:33,381,231...33,392,766
|
|
G |
Hrg |
histidine-rich glycoprotein |
decreases expression |
ISO |
glycidol results in decreased expression of HRG mRNA |
CTD |
PMID:33187795 |
|
NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
|
|
G |
Hrk |
harakiri, BCL2 interacting protein |
increases expression |
EXP |
glycidol results in increased expression of HRK mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr12:38,387,484...38,409,652
|
|
G |
Hs3st3a1 |
heparan sulfate-glucosamine 3-sulfotransferase 3A1 |
increases expression |
EXP |
glycidol results in increased expression of HS3ST3A1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:49,092,850...49,180,676
Ensembl chr10:49,094,026...49,180,676
|
|
G |
Hs3st3b1 |
heparan sulfate-glucosamine 3-sulfotransferase 3B1 |
increases expression |
EXP |
glycidol results in increased expression of HS3ST3B1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970
|
|
G |
Hs6st2 |
heparan sulfate 6-O-sulfotransferase 2 |
increases expression |
EXP |
glycidol results in increased expression of HS6ST2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:130,966,547...131,261,629
Ensembl chr X:130,968,385...131,261,492
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
glycidol results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsf4 |
heat shock transcription factor 4 |
increases expression |
EXP |
glycidol results in increased expression of HSF4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr19:33,147,755...33,153,479
Ensembl chr19:33,147,755...33,153,479
|
|
G |
Hspa12b |
heat shock protein family A (Hsp70) member 12B |
increases expression |
EXP |
glycidol results in increased expression of HSPA12B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:118,346,372...118,364,374
Ensembl chr 3:118,346,354...118,364,737
|
|
G |
Htr7 |
5-hydroxytryptamine receptor 7 |
increases expression |
EXP |
glycidol results in increased expression of HTR7 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
|
|
G |
Hypk |
Huntingtin interacting protein K |
decreases expression |
EXP |
glycidol results in decreased expression of HYPK mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:108,434,997...108,436,370
Ensembl chr 3:108,432,539...108,436,370
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of ID3 mRNA glycidol results in increased expression of ID3 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Ier2 |
immediate early response 2 |
decreases expression |
EXP |
glycidol results in decreased expression of IER2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
decreases expression |
EXP |
glycidol results in decreased expression of IFI27 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of IGF1 mRNA glycidol results in increased methylation of IGF1 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf2 |
insulin-like growth factor 2 |
increases expression |
EXP |
glycidol results in increased expression of IGF2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in increased expression of IGFBP1 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
increases expression |
EXP |
glycidol results in increased expression of IGFBP2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
decreases expression |
EXP |
glycidol results in decreased expression of IGFBP3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Igsf1 |
immunoglobulin superfamily, member 1 |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of IGSF1 mRNA glycidol results in increased expression of IGSF1 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr X:129,069,891...129,085,331
Ensembl chr X:129,069,896...129,085,139
|
|
G |
Igsf21 |
immunoglobin superfamily, member 21 |
decreases expression |
EXP |
glycidol results in decreased expression of IGSF21 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:152,287,834...152,512,174
Ensembl chr 5:152,287,835...152,512,174
|
|
G |
Igsf9b |
immunoglobulin superfamily, member 9B |
increases expression |
EXP |
glycidol results in increased expression of IGSF9B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:25,712,644...25,769,481
Ensembl chr 8:25,712,644...25,758,554
|
|
G |
Ihh |
Indian hedgehog signaling molecule |
decreases expression |
EXP |
glycidol results in decreased expression of IHH mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
|
|
G |
Il10ra |
interleukin 10 receptor subunit alpha |
increases expression |
EXP |
glycidol results in increased expression of IL10RA mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:45,563,009...45,578,041
Ensembl chr 8:45,563,137...45,578,061
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
EXP |
[glycidol co-treated with alpha-Chlorohydrin] results in increased expression of IL1B protein glycidol results in increased expression of IL1B protein |
CTD |
PMID:33187795 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
decreases expression |
EXP |
glycidol results in decreased expression of IL1RN mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
|
|
G |
Il25 |
interleukin 25 |
increases expression |
EXP |
glycidol results in increased expression of IL25 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:28,408,766...28,412,157
Ensembl chr15:28,408,842...28,411,893
|
|
G |
Il6r |
interleukin 6 receptor |
increases expression |
EXP |
glycidol results in increased expression of IL6R mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
|
|
G |
Iqsec2 |
IQ motif and Sec7 domain ArfGEF 2 |
decreases expression |
EXP |
glycidol results in decreased expression of IQSEC2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:21,254,799...21,337,179
Ensembl chr X:21,254,914...21,336,584
|
|
G |
Irx6 |
iroquois homeobox 6 |
increases expression |
EXP |
glycidol results in increased expression of IRX6 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr19:14,330,440...14,336,403
Ensembl chr19:14,330,440...14,336,403
|
|
G |
Itga10 |
integrin subunit alpha 10 |
increases expression |
EXP |
glycidol results in increased expression of ITGA10 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:184,182,869...184,202,172
Ensembl chr 2:184,182,869...184,202,172
|
|
G |
Itgb4 |
integrin subunit beta 4 |
increases expression |
EXP |
glycidol results in increased expression of ITGB4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Itih2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
increases expression |
EXP |
glycidol results in increased expression of ITIH2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr17:68,375,574...68,411,849
Ensembl chr17:68,375,567...68,411,841
|
|
G |
Jpt2 |
Jupiter microtubule associated homolog 2 |
decreases expression |
EXP |
glycidol results in decreased expression of JPT2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:13,963,135...13,983,212
Ensembl chr10:13,963,137...13,983,170
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
glycidol results in decreased expression of JUN mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
glycidol results in decreased expression of JUNB mRNA |
CTD |
PMID:24915197 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kalrn |
kalirin, RhoGEF kinase |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of KALRN promoter glycidol results in decreased expression of KALRN mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr11:66,198,155...66,803,166
Ensembl chr11:66,198,173...66,797,610
|
|
G |
Kbtbd4 |
kelch repeat and BTB domain containing 4 |
increases expression |
EXP |
glycidol results in increased expression of KBTBD4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:76,883,671...76,889,769
Ensembl chr 3:76,883,014...76,890,799
|
|
G |
Kcne2 |
potassium voltage-gated channel subfamily E regulatory subunit 2 |
increases expression |
EXP |
glycidol results in increased expression of KCNE2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr11:31,517,176...31,530,026
Ensembl chr11:31,295,614...31,530,043
|
|
G |
Kcne5 |
potassium voltage-gated channel subfamily E regulatory subunit 5 |
decreases expression |
EXP |
glycidol results in decreased expression of KCNE5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr X:105,930,398...105,931,013
Ensembl chr X:105,930,398...105,931,013
|
|
G |
Kcnj13 |
potassium inwardly-rectifying channel, subfamily J, member 13 |
increases expression |
EXP |
glycidol results in increased expression of KCNJ13 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:88,063,003...88,071,112
Ensembl chr 9:88,063,003...88,071,112
|
|
G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
increases expression |
EXP |
glycidol results in increased expression of KCNJ16 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:95,990,009...96,021,356
Ensembl chr10:95,960,725...96,021,702
|
|
G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
decreases expression |
EXP |
glycidol results in decreased expression of KCNJ3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:39,944,896...40,106,646
Ensembl chr 3:39,945,351...40,109,124
|
|
G |
Kcnk10 |
potassium two pore domain channel subfamily K member 10 |
decreases expression |
EXP |
glycidol results in decreased expression of KCNK10 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 6:117,690,052...117,826,120
Ensembl chr 6:117,694,222...117,825,695
|
|
G |
Kcnk5 |
potassium two pore domain channel subfamily K member 5 |
decreases expression |
EXP |
glycidol results in decreased expression of KCNK5 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:4,122,442...4,164,718
Ensembl chr15:4,122,442...4,164,718
|
|
G |
Kcnq1 |
potassium voltage-gated channel subfamily Q member 1 |
increases expression |
EXP |
glycidol results in increased expression of KCNQ1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:198,291,711...198,624,683
Ensembl chr 1:198,291,766...198,624,669
|
|
G |
Kcnq4 |
potassium voltage-gated channel subfamily Q member 4 |
decreases expression |
EXP |
glycidol results in decreased expression of KCNQ4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:134,275,145...134,326,992
Ensembl chr 5:134,275,934...134,326,932
|
|
G |
Kdf1 |
keratinocyte differentiation factor 1 |
increases expression |
EXP |
glycidol results in increased expression of KDF1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:145,744,753...145,758,150
Ensembl chr 5:145,745,099...145,755,878
|
|
G |
Kdm2b |
lysine demethylase 2B |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of KDM2B mRNA glycidol results in increased methylation of KDM2B promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr12:33,566,530...33,701,366
Ensembl chr12:33,574,657...33,701,355
|
|
G |
Kdm6b |
lysine demethylase 6B |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of KDM6B mRNA glycidol results in increased methylation of KDM6B promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
|
|
G |
Kdr |
kinase insert domain receptor |
decreases expression |
EXP |
glycidol results in decreased expression of KDR mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Kif11 |
kinesin family member 11 |
decreases expression |
EXP |
glycidol results in decreased expression of KIF11 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif13b |
kinesin family member 13B |
decreases expression |
EXP |
glycidol results in decreased expression of KIF13B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:38,908,257...39,066,021
Ensembl chr15:38,924,624...39,084,879
|
|
G |
Kif18b |
kinesin family member 18B |
decreases expression |
EXP |
glycidol results in decreased expression of KIF18B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:87,870,424...87,889,895
Ensembl chr10:87,870,428...87,889,850
|
|
G |
Kif20b |
kinesin family member 20B |
increases expression |
EXP |
glycidol results in increased expression of KIF20B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
|
|
G |
Kif2c |
kinesin family member 2C |
decreases expression |
EXP |
glycidol results in decreased expression of KIF2C mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
|
|
G |
Kif6 |
kinesin family member 6 |
decreases expression |
EXP |
glycidol results in decreased expression of KIF6 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:11,076,203...11,373,205
Ensembl chr 9:11,072,824...11,373,006
|
|
G |
Kl |
Klotho |
increases expression |
EXP |
glycidol results in increased expression of KL mRNA |
CTD |
PMID:24395379 |
|
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
|
|
G |
Klf2 |
KLF transcription factor 2 |
decreases expression |
EXP |
glycidol results in decreased expression of KLF2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klf4 |
KLF transcription factor 4 |
decreases expression |
EXP |
glycidol results in decreased expression of KLF4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klk6 |
kallikrein related-peptidase 6 |
decreases expression |
EXP |
glycidol results in decreased expression of KLK6 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:94,278,863...94,286,136
Ensembl chr 1:94,280,340...94,286,121
|
|
G |
Knstrn |
kinetochore-localized astrin/SPAG5 binding protein |
decreases expression |
EXP |
glycidol results in decreased expression of KNSTRN mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715
|
|
G |
Krt18 |
keratin 18 |
increases expression |
EXP |
glycidol results in increased expression of KRT18 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
|
|
G |
Krt19 |
keratin 19 |
increases expression |
ISO |
glycidol results in increased expression of KRT19 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt24 |
keratin 24 |
increases expression |
EXP |
glycidol results in increased expression of KRT24 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:84,232,163...84,237,299
Ensembl chr10:84,232,164...84,237,299
|
|
G |
Krt27 |
keratin 27 |
decreases expression |
EXP |
glycidol results in decreased expression of KRT27 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:84,298,684...84,303,967
Ensembl chr10:84,298,508...84,303,967
|
|
G |
Krtdap |
keratinocyte differentiation associated protein |
increases expression |
EXP |
glycidol results in increased expression of KRTDAP mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:86,038,296...86,041,594
Ensembl chr 1:86,038,437...86,041,455
|
|
G |
Ktn1 |
kinectin 1 |
decreases expression |
EXP |
glycidol results in decreased expression of KTN1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:20,913,665...21,002,588
Ensembl chr15:20,914,642...21,002,578
|
|
G |
Lacc1 |
laccase domain containing 1 |
increases expression |
EXP |
glycidol results in increased expression of LACC1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:52,390,267...52,407,630
Ensembl chr15:52,395,183...52,407,545
|
|
G |
Lars2 |
leucyl-tRNA synthetase 2, mitochondrial |
increases expression |
EXP |
glycidol results in increased expression of LARS2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:123,010,271...123,106,395
Ensembl chr 8:123,010,293...123,106,395
|
|
G |
Lbr |
lamin B receptor |
increases expression |
EXP |
glycidol results in increased expression of LBR mRNA |
CTD |
PMID:24395379 |
|
NCBI chr13:93,539,386...93,564,026
Ensembl chr13:93,538,920...93,564,017
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in increased expression of LCN2 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lcorl |
ligand dependent nuclear receptor corepressor-like |
decreases expression |
EXP |
glycidol results in decreased expression of LCORL mRNA |
CTD |
PMID:24395379 |
|
NCBI chr14:65,271,339...65,407,732
Ensembl chr14:65,271,135...65,404,174
|
|
G |
Lcp2 |
lymphocyte cytosolic protein 2 |
decreases expression |
EXP |
glycidol results in decreased expression of LCP2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:18,642,600...18,689,562
Ensembl chr10:18,642,658...18,689,559
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
decreases expression |
ISO |
glycidol results in decreased expression of LEF1 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
|
|
G |
Lepr |
leptin receptor |
decreases expression |
EXP |
glycidol results in decreased expression of LEPR mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lgals3bp |
galectin 3 binding protein |
decreases expression |
EXP |
glycidol results in decreased expression of LGALS3BP mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
|
|
G |
Lhb |
luteinizing hormone subunit beta |
increases expression |
EXP |
glycidol results in increased expression of LHB mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lhx5 |
LIM homeobox 5 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of LHX5 mRNA glycidol results in increased methylation of LHX5 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr12:36,126,186...36,134,625
Ensembl chr12:36,126,186...36,134,625
|
|
G |
Lim2 |
lens intrinsic membrane protein 2 |
increases expression decreases expression |
EXP |
glycidol results in increased expression of LIM2 mRNA glycidol results in decreased expression of LIM2 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 1:93,837,597...93,843,769
Ensembl chr 1:93,837,597...93,843,769
|
|
G |
Lima1 |
LIM domain and actin binding 1 |
decreases expression |
EXP |
glycidol results in decreased expression of LIMA1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:130,901,717...131,001,512
Ensembl chr 7:130,901,717...131,001,473
|
|
G |
Lipe |
lipase E, hormone sensitive type |
decreases expression |
EXP |
glycidol results in decreased expression of LIPE mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:80,965,612...80,984,313
Ensembl chr 1:80,965,627...80,984,310
|
|
G |
Lipogenin |
Lipogenin |
increases expression |
EXP |
glycidol results in increased expression of LIPOGENIN mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:57,356,298...57,357,553
|
|
G |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
increases expression |
EXP |
glycidol results in increased expression of LMX1A mRNA |
CTD |
PMID:24395379 |
|
NCBI chr13:79,834,614...79,978,253
Ensembl chr13:79,835,019...79,978,253
|
|
G |
Lox |
lysyl oxidase |
increases expression |
EXP |
glycidol results in increased expression of LOX mRNA |
CTD |
PMID:24395379 |
|
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
|
|
G |
Lrrc17 |
leucine rich repeat containing 17 |
decreases expression |
EXP |
glycidol results in decreased expression of LRRC17 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:13,501,428...13,531,845
Ensembl chr 4:13,501,436...13,531,845
|
|
G |
Lrrc46 |
leucine rich repeat containing 46 |
increases expression |
EXP |
glycidol results in increased expression of LRRC46 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:82,021,314...82,033,575
Ensembl chr10:82,021,330...82,033,724
|
|
G |
Lrrc8e |
leucine rich repeat containing 8 VRAC subunit E |
increases expression |
EXP |
glycidol results in increased expression of LRRC8E mRNA |
CTD |
PMID:24395379 |
|
NCBI chr12:2,578,240...2,589,407
Ensembl chr12:2,578,315...2,589,412
|
|
G |
Lsp1 |
lymphocyte-specific protein 1 |
increases expression decreases expression |
EXP |
glycidol results in increased expression of LSP1 mRNA glycidol results in decreased expression of LSP1 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 1:197,614,677...197,648,414
Ensembl chr 1:197,614,687...197,648,416
|
|
G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
increases expression |
EXP |
glycidol results in increased expression of LTBP2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
|
|
G |
Lum |
lumican |
decreases expression |
EXP |
glycidol results in decreased expression of LUM mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:32,358,990...32,365,794
Ensembl chr 7:32,358,614...32,365,793
|
|
G |
Lvrn |
laeverin |
decreases expression |
EXP |
glycidol results in decreased expression of LVRN mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:39,606,047...39,675,247
Ensembl chr18:39,607,722...39,675,165
|
|
G |
Ly6g6d |
lymphocyte antigen 6 family member G6D |
decreases expression |
EXP |
glycidol results in decreased expression of LY6G6D mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:3,741,973...3,752,378
Ensembl chr20:3,737,459...3,752,248
|
|
G |
Lyrm1 |
LYR motif containing 1 |
decreases expression |
EXP |
glycidol results in decreased expression of LYRM1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:174,284,116...174,305,053
Ensembl chr 1:174,284,602...174,305,053
|
|
G |
Mab21l4 |
mab-21 like 4 |
increases expression |
EXP |
glycidol results in increased expression of MAB21L4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:93,690,455...93,701,267
Ensembl chr 9:93,690,999...93,700,506
|
|
G |
Mag |
myelin-associated glycoprotein |
decreases expression |
EXP |
glycidol results in decreased expression of MAG mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:86,148,227...86,163,726
Ensembl chr 1:86,148,228...86,163,656
|
|
G |
Mal |
mal, T-cell differentiation protein |
decreases expression |
EXP |
glycidol results in decreased expression of MAL mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
|
|
G |
Mall |
mal, T-cell differentiation protein-like |
increases expression |
EXP |
glycidol results in increased expression of MALL mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:114,927,897...114,950,840
Ensembl chr 3:114,927,897...114,950,785
|
|
G |
Mamdc2 |
MAM domain containing 2 |
decreases expression |
EXP |
glycidol results in decreased expression of MAMDC2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:220,863,959...221,016,493
Ensembl chr 1:220,863,976...221,016,354
|
|
G |
Mapk10 |
mitogen activated protein kinase 10 |
increases expression |
ISO |
glycidol results in increased expression of MAPK10 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201
|
|
G |
Mapk15 |
mitogen-activated protein kinase 15 |
increases expression |
EXP |
glycidol results in increased expression of MAPK15 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:107,694,907...107,714,640
Ensembl chr 7:107,694,964...107,714,645
|
|
G |
Mapk8ip3 |
mitogen-activated protein kinase 8 interacting protein 3 |
decreases expression |
EXP |
glycidol results in decreased expression of MAPK8IP3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273
|
|
G |
Mas1 |
MAS1 proto-oncogene, G protein-coupled receptor |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of MAS1 mRNA glycidol results in increased methylation of MAS1 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
|
|
G |
Mast2 |
microtubule associated serine/threonine kinase 2 |
decreases expression |
EXP |
glycidol results in decreased expression of MAST2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:129,776,293...129,915,502
Ensembl chr 5:129,775,676...129,915,606
|
|
G |
Mcam |
melanoma cell adhesion molecule |
decreases expression |
EXP |
glycidol results in decreased expression of MCAM mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
|
|
G |
Mcm10 |
minichromosome maintenance 10 replication initiation factor |
decreases expression |
EXP |
glycidol results in decreased expression of MCM10 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
increases expression |
EXP |
glycidol results in increased expression of MCM5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
|
|
G |
Mdfic |
MyoD family inhibitor domain containing |
increases expression |
EXP |
glycidol results in increased expression of MDFIC mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 4:43,972,310...44,052,162
Ensembl chr 4:43,972,507...44,052,161
|
|
G |
Mdk |
midkine |
increases expression |
EXP |
glycidol results in increased expression of MDK mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:77,901,134...77,903,997
Ensembl chr 3:77,901,158...77,903,130
|
|
G |
Mei1 |
meiotic double-stranded break formation protein 1 |
decreases expression |
EXP |
glycidol results in decreased expression of MEI1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:113,590,142...113,643,513
Ensembl chr 7:113,590,142...113,643,511
|
|
G |
Melk |
maternal embryonic leucine zipper kinase |
decreases expression |
EXP |
glycidol results in decreased expression of MELK mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:58,540,393...58,600,562
Ensembl chr 5:58,540,449...58,600,937
|
|
G |
Meox2 |
mesenchyme homeobox 2 |
decreases expression |
EXP |
glycidol results in decreased expression of MEOX2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:53,856,760...53,917,467
Ensembl chr 6:53,856,758...53,917,467
|
|
G |
Mep1b |
meprin A subunit beta |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of MEP1B mRNA |
CTD |
PMID:33187795 |
|
NCBI chr18:12,366,126...12,392,840
Ensembl chr18:12,365,289...12,392,840
|
|
G |
Mettl24 |
methyltransferase like 24 |
decreases expression |
EXP |
glycidol results in decreased expression of METTL24 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:44,142,126...44,264,651
Ensembl chr20:44,142,396...44,261,310
|
|
G |
Mfrp |
membrane frizzled-related protein |
increases expression |
EXP |
glycidol results in increased expression of MFRP mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:44,445,636...44,450,859
Ensembl chr 8:44,445,697...44,450,859
|
|
G |
Mfsd2a |
MFSD2 lysolipid transporter A, lysophospholipid |
decreases expression |
EXP |
glycidol results in decreased expression of MFSD2A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
glycidol results in increased expression of MGMT mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mgp |
matrix Gla protein |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in increased expression of MGP mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
|
|
G |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
decreases expression |
EXP |
glycidol results in decreased expression of MICAL3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:154,152,776...154,353,274
Ensembl chr 4:154,153,834...154,302,590
|
|
G |
Micb |
MHC class I polypeptide-related sequence B |
increases expression |
EXP |
glycidol results in increased expression of MICB mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:78,495,779...78,513,030
Ensembl chr 1:78,495,779...78,512,827
|
|
G |
Mir21 |
microRNA 21 |
affects expression |
EXP |
glycidol affects the expression of MIR21 mRNA |
CTD |
PMID:34461274 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mkrn3 |
makorin, ring finger protein, 3 |
increases expression |
EXP |
glycidol results in increased expression of MKRN3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:115,926,774...115,929,288
Ensembl chr 1:115,926,776...115,929,283
|
|
G |
Mlkl |
mixed lineage kinase domain like pseudokinase |
increases phosphorylation multiple interactions |
EXP |
glycidol results in increased phosphorylation of MLKL protein [glycidol co-treated with alpha-Chlorohydrin] results in increased phosphorylation of MLKL protein |
CTD |
PMID:33187795 |
|
NCBI chr19:39,277,526...39,304,555
Ensembl chr19:39,276,785...39,304,502
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression |
EXP |
glycidol results in increased expression of MMP2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mobp |
myelin-associated oligodendrocyte basic protein |
decreases expression |
EXP |
glycidol results in decreased expression of MOBP mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:119,869,504...119,899,605
Ensembl chr 8:119,869,626...119,899,563
|
|
G |
Mon1b |
MON1 homolog B, secretory trafficking associated |
increases expression |
EXP |
glycidol results in increased expression of MON1B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr19:41,617,372...41,625,347
Ensembl chr19:41,617,364...41,625,347
|
|
G |
Mpz |
myelin protein zero |
decreases expression |
EXP |
glycidol results in decreased expression of MPZ mRNA |
CTD |
PMID:24395379 |
|
NCBI chr13:83,570,811...83,576,680
Ensembl chr13:83,570,811...83,576,679
|
|
G |
Mrap |
melanocortin 2 receptor accessory protein |
decreases expression |
EXP |
glycidol results in decreased expression of MRAP mRNA |
CTD |
PMID:24395379 |
|
NCBI chr11:29,991,974...30,003,024
Ensembl chr11:29,992,034...30,003,024
|
|
G |
Mrgprd |
MAS related GPR family member D |
affects expression |
EXP |
glycidol affects the expression of MRGPRD mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:200,479,204...200,487,902
Ensembl chr 1:200,485,189...200,486,148
|
|
G |
Ms4a6a |
membrane spanning 4-domains A6A |
increases expression |
EXP |
glycidol results in increased expression of MS4A6A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:208,401,466...208,414,758
|
|
G |
Ms4a8 |
membrane spanning 4-domains A8 |
increases expression |
EXP |
glycidol results in increased expression of MS4A8 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:207,730,665...207,744,260
Ensembl chr 1:207,730,665...207,744,324
|
|
G |
Msc |
musculin |
decreases expression |
EXP |
glycidol results in decreased expression of MSC mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:4,547,335...4,553,206
Ensembl chr 5:4,547,405...4,553,203
|
|
G |
Msx1 |
msh homeobox 1 |
increases expression |
EXP |
glycidol results in increased expression of MSX1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr14:72,961,036...72,964,970
Ensembl chr14:72,961,148...72,964,966
|
|
G |
Mt1 |
metallothionein 1 |
increases expression |
EXP |
glycidol results in increased expression of MT1A mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mtcp1 |
mature T-cell proliferation 1 |
decreases expression |
EXP |
glycidol results in decreased expression of MTCP1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:126,189...130,123
|
|
G |
Mtus1 |
microtubule associated scaffold protein 1 |
decreases expression |
EXP |
glycidol results in decreased expression of MTUS1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr16:51,202,497...51,347,794
Ensembl chr16:51,253,562...51,347,793
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
increases expression decreases expression |
EXP |
glycidol results in increased expression of MYBL2 mRNA glycidol results in decreased expression of MYBL2 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Mybpc3 |
myosin binding protein C3 |
increases expression |
EXP |
glycidol results in increased expression of MYBPC3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:77,095,165...77,113,406
Ensembl chr 3:77,095,252...77,113,405
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
affects expression affects methylation |
EXP |
glycidol affects the expression of MYC mRNA glycidol affects the methylation of MYC promoter |
CTD |
PMID:27884059 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh1 |
myosin heavy chain 1 |
decreases expression |
EXP |
glycidol results in decreased expression of MYH1 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr10:51,885,913...51,909,699
Ensembl chr10:51,885,913...51,946,295
|
|
G |
Myh8 |
myosin heavy chain 8 |
decreases expression |
EXP |
glycidol results in decreased expression of MYH8 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:51,963,510...51,993,103
Ensembl chr10:51,963,510...51,993,232
|
|
G |
Myo1d |
myosin ID |
decreases expression |
EXP |
glycidol results in decreased expression of MYO1D mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:65,489,153...65,765,812
Ensembl chr10:65,489,154...65,766,349
|
|
G |
Myo1e |
myosin IE |
decreases expression |
EXP |
glycidol results in decreased expression of MYO1E mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:70,887,934...71,080,180
Ensembl chr 8:70,887,870...71,080,169
|
|
G |
Myorg |
myogenesis regulating glycosidase |
decreases expression |
EXP |
glycidol results in decreased expression of MYORG mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:56,654,257...56,664,467
Ensembl chr 5:56,648,643...56,664,440
|
|
G |
Myrf |
myelin regulatory factor |
decreases expression |
EXP |
glycidol results in decreased expression of MYRF mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:206,854,175...206,886,276
Ensembl chr 1:206,854,175...206,886,157
|
|
G |
N4bp3 |
Nedd4 binding protein 3 |
increases expression |
EXP |
glycidol results in increased expression of N4BP3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001
|
|
G |
Nags |
N-acetylglutamate synthase |
decreases expression |
EXP |
glycidol results in decreased expression of NAGS mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:87,098,330...87,102,465
Ensembl chr10:87,098,330...87,102,465
|
|
G |
Napsa |
napsin A aspartic peptidase |
multiple interactions |
ISO |
[alpha-Chlorohydrin co-treated with glycidol] results in decreased expression of NAPSA mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 1:95,064,726...95,077,101
Ensembl chr 1:95,064,900...95,077,094
|
|
G |
Nat8f3 |
N-acetyltransferase 8 (GCN5-related) family member 3 |
decreases expression |
EXP |
glycidol results in decreased expression of NAT8F3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:118,241,792...118,246,010
Ensembl chr 4:118,239,304...118,285,500
|
|
G |
Ncam2 |
neural cell adhesion molecule 2 |
decreases expression |
EXP |
glycidol results in decreased expression of NCAM2 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr11:20,104,974...20,592,168
Ensembl chr11:20,104,925...20,591,984
|
|
G |
Ndc80 |
NDC80 kinetochore complex component |
decreases expression |
EXP |
glycidol results in decreased expression of NDC80 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
|
|
G |
Ndufc2 |
NADH:ubiquinone oxidoreductase subunit C2 |
decreases expression |
EXP |
glycidol results in decreased expression of NDUFC2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:151,711,965...151,718,188
Ensembl chr 1:151,711,901...151,718,189
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
decreases expression |
EXP |
glycidol results in decreased expression of NEDD9 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
|
|
G |
Neurod2 |
neuronal differentiation 2 |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of NEUROD2 mRNA glycidol results in increased methylation of NEUROD2 promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr10:83,323,801...83,327,986
Ensembl chr10:83,324,442...83,327,986
|
|
G |
Nfasc |
neurofascin |
decreases expression |
EXP |
glycidol results in decreased expression of NFASC mRNA |
CTD |
PMID:24395379 |
|
NCBI chr13:43,997,223...44,183,863
Ensembl chr13:43,997,224...44,183,880
|
|
G |
Nfic |
nuclear factor I/C |
affects expression |
EXP |
glycidol affects the expression of NFIC mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:8,278,210...8,309,936
Ensembl chr 7:8,253,361...8,309,936
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
decreases expression |
EXP |
glycidol results in decreased expression of NFKBIA mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
decreases expression |
EXP |
glycidol results in decreased expression of NFKBIZ mRNA |
CTD |
PMID:24915197 |
|
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Ngf |
nerve growth factor |
decreases expression |
EXP |
glycidol results in decreased expression of NGF mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nherf1 |
NHERF family PDZ scaffold protein 1 |
increases expression |
ISO |
glycidol results in increased expression of NHERF1 protein |
CTD |
PMID:22434383 |
|
NCBI chr10:100,403,189...100,420,290
Ensembl chr10:100,403,069...100,420,598
|
|
G |
Nkg7 |
natural killer cell granule protein 7 |
increases expression |
EXP |
glycidol results in increased expression of NKG7 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:93,844,748...93,845,975
Ensembl chr 1:93,844,902...93,845,983
|
|
G |
Nkx2-6 |
NK2 homeobox 6 |
increases expression |
EXP |
glycidol results in increased expression of NKX2-6 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:44,443,151...44,447,248
Ensembl chr15:44,443,101...44,447,247
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions increases expression |
EXP |
alpha-Chlorohydrin promotes the reaction [glycidol results in increased expression of NLRP3 protein]; glycidol promotes the reaction [alpha-Chlorohydrin results in increased expression of NLRP3 protein] |
CTD |
PMID:33187795 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Notch3 |
notch receptor 3 |
decreases expression |
EXP |
glycidol results in decreased expression of NOTCH3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Npas4 |
neuronal PAS domain protein 4 |
decreases expression |
EXP |
glycidol results in decreased expression of NPAS4 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 1:202,281,260...202,298,681
Ensembl chr 1:202,281,958...202,286,724
|
|
G |
Nphp4 |
nephrocystin 4 |
increases expression |
EXP |
glycidol results in increased expression of NPHP4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:162,986,157...163,073,708
Ensembl chr 5:162,988,370...163,073,706
|
|
G |
Npr1 |
natriuretic peptide receptor 1 |
decreases expression |
EXP |
glycidol results in decreased expression of NPR1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:175,934,181...175,949,505
|
|
G |
Npy |
neuropeptide Y |
decreases expression |
EXP |
glycidol results in decreased expression of NPY mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
|
|
G |
Npy5r |
neuropeptide Y receptor Y5 |
decreases expression |
EXP |
glycidol results in decreased expression of NPY5R mRNA |
CTD |
PMID:24915197 |
|
NCBI chr16:23,055,427...23,063,384
Ensembl chr16:23,055,427...23,063,382
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
decreases expression |
EXP |
glycidol results in decreased expression of NR4A1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of NR4A2 mRNA glycidol results in increased expression of NR4A2 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
decreases expression |
EXP |
glycidol results in decreased expression of NR4A3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
|
|
G |
Nrep |
neuronal regeneration related protein |
decreases expression |
EXP |
glycidol results in decreased expression of NREP mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
|
|
G |
Nrn1l |
neuritin 1-like |
increases expression |
EXP |
glycidol results in increased expression of NRN1L mRNA |
CTD |
PMID:24395379 |
|
NCBI chr19:33,786,419...33,787,879
|
|
G |
Ntf3 |
neurotrophin 3 |
decreases expression |
EXP |
glycidol results in decreased expression of NTF3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
|
|
G |
Ntsr1 |
neurotensin receptor 1 |
increases expression |
EXP |
glycidol results in increased expression of NTSR1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
|
|
G |
Nupr1 |
nuclear protein 1, transcriptional regulator |
increases expression |
ISO |
glycidol results in increased expression of NUPR1 mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
|
|
G |
Ogn |
osteoglycin |
decreases expression |
EXP |
glycidol results in decreased expression of OGN mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,032,069...15,052,739
|
|
G |
Olfml3 |
olfactomedin-like 3 |
increases expression |
EXP |
glycidol results in increased expression of OLFML3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
|
|
G |
Olr1523 |
olfactory receptor 1523 |
decreases expression |
EXP |
glycidol results in decreased expression of OLR1523 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:72,708,272...72,709,213
Ensembl chr10:72,707,063...72,715,311
|
|
G |
Olr59 |
olfactory receptor 59 |
decreases expression |
EXP |
glycidol results in decreased expression of OLR59 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:157,193,051...157,227,707
Ensembl chr 1:157,193,080...157,211,179
|
|
G |
Opalin |
oligodendrocytic myelin paranodal and inner loop protein |
decreases expression |
EXP |
glycidol results in decreased expression of OPALIN mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:239,891,137...239,909,388
Ensembl chr 1:239,891,142...239,908,788
|
|
G |
Or10am5 |
olfactory receptor family 10 subfamily AM member 5 |
decreases expression |
EXP |
glycidol results in decreased expression of OR10AM5 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:67,335,054...67,336,007
Ensembl chr 1:67,326,477...67,338,183
|
|
G |
Or10g9b |
olfactory receptor family 10 subfamily G member 9B |
decreases expression |
EXP |
glycidol results in decreased expression of OR10G9B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:40,358,211...40,359,143
Ensembl chr 8:40,357,714...40,361,692
|
|
G |
Or1d2 |
olfactory receptor family 1 subfamily D member 2 |
increases expression |
EXP |
glycidol results in increased expression of OR1D2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:59,212,947...59,213,882
Ensembl chr10:59,207,257...59,214,085
|
|
G |
Or2v1 |
olfactory receptor family 2 subfamily V member 1 |
decreases expression |
EXP |
glycidol results in decreased expression of OR2V1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:33,399,891...33,404,298
Ensembl chr10:33,398,913...33,404,401
|
|
G |
Or2y1i |
olfactory receptor family 2 subfamily Y member 1I |
decreases expression |
EXP |
glycidol results in decreased expression of OR2Y1I mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:33,737,199...33,738,128
Ensembl chr10:33,732,012...33,738,729
|
|
G |
Or4c15 |
olfactory receptor family 4 subfamily C member 15 |
increases expression |
EXP |
glycidol results in increased expression of OR4C15 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:74,692,006...74,694,901
Ensembl chr 3:74,689,082...74,707,227
|
|
G |
Or51b6 |
olfactory receptor family 51 subfamily B member 6 |
decreases expression |
EXP |
glycidol results in decreased expression of OR51B6 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:158,347,649...158,348,596
Ensembl chr 1:158,344,509...158,349,843
|
|
G |
Or51i2 |
olfactory receptor family 51 subfamily I member 2 |
decreases expression |
EXP |
glycidol results in decreased expression of OR51I2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:158,513,673...158,514,611
Ensembl chr 1:158,513,673...158,514,611
|
|
G |
Or52z1 |
olfactory receptor family 52 subfamily Z member 1 |
increases expression |
EXP |
glycidol results in increased expression of OR52Z1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:158,206,284...158,207,246
|
|
G |
Or5aq1d |
olfactory receptor family 5 subfamily AQ member 1D |
increases expression |
EXP |
glycidol results in increased expression of OR5AQ1D mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:72,375,994...72,383,570
Ensembl chr 3:72,378,931...72,508,391
|
|
G |
Or8b8 |
olfactory receptor family 8 subfamily B member 8 |
decreases expression |
EXP |
glycidol results in decreased expression of OR8B8 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:37,693,578...37,694,510
Ensembl chr 8:37,693,499...37,694,547
|
|
G |
Otog |
otogelin |
increases expression |
EXP |
glycidol results in increased expression of OTOG mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:96,746,336...96,815,416
Ensembl chr 1:96,746,336...96,815,415
|
|
G |
Otos |
otospiralin |
decreases expression |
EXP |
glycidol results in decreased expression of OTOS mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 9:93,216,948...93,220,614
Ensembl chr 9:93,216,948...93,218,466
|
|
G |
Otx2 |
orthodenticle homeobox 2 |
increases expression |
EXP |
glycidol results in increased expression of OTX2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:21,942,233...21,953,034
Ensembl chr15:21,943,191...21,953,416
|
|
G |
Oxnad1 |
oxidoreductase NAD-binding domain containing 1 |
decreases expression |
EXP |
glycidol results in decreased expression of OXNAD1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr16:7,293,470...7,322,540
Ensembl chr16:7,293,470...7,322,540
|
|
G |
P2ry1 |
purinergic receptor P2Y1 |
decreases expression |
EXP |
glycidol results in decreased expression of P2RY1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:145,241,975...145,248,186
Ensembl chr 2:145,241,849...145,248,457
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
decreases expression |
EXP |
glycidol results in decreased expression of P2RY2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:155,352,050...155,367,423
Ensembl chr 1:155,351,165...155,367,632
|
|
G |
Padi2 |
peptidyl arginine deiminase 2 |
decreases expression |
EXP |
glycidol results in decreased expression of PADI2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:153,209,053...153,251,632
Ensembl chr 5:153,209,053...153,251,632
|
|
G |
Pah |
phenylalanine hydroxylase |
decreases expression |
EXP |
glycidol results in decreased expression of PAH mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
|
|
G |
Palmd |
palmdelphin |
decreases expression |
EXP |
glycidol results in decreased expression of PALMD mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
increases expression |
EXP |
glycidol results in increased expression of PARG mRNA |
CTD |
PMID:24395379 |
|
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
|
|
G |
Parp14 |
poly (ADP-ribose) polymerase family, member 14 |
decreases expression |
EXP |
glycidol results in decreased expression of PARP14 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
|
|
G |
Parvg |
parvin, gamma |
increases expression |
EXP |
glycidol results in increased expression of PARVG mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:115,456,183...115,475,707
Ensembl chr 7:115,456,209...115,475,104
|
|
G |
Pbk |
PDZ binding kinase |
decreases expression |
EXP |
glycidol results in decreased expression of PBK mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
|
|
G |
Pbld1 |
phenazine biosynthesis-like protein domain containing 1 |
increases expression |
EXP |
glycidol results in increased expression of PBLD mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
|
|
G |
Pcdh20 |
protocadherin 20 |
decreases expression |
EXP |
glycidol results in decreased expression of PCDH20 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:64,425,534...64,431,790
Ensembl chr15:64,425,534...64,431,790
|
|
G |
Pcdhb20 |
protocadherin beta 20 |
decreases expression |
EXP |
glycidol results in decreased expression of PCDHB10 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:29,211,878...29,215,272
Ensembl chr18:29,211,883...29,215,258
|
|
G |
Pcdhga10 |
protocadherin gamma subfamily A, 10 |
increases expression |
EXP |
glycidol results in increased expression of PCDHGA10 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:29,574,693...29,667,865
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pcdhga11 |
protocadherin gamma subfamily A, 11 |
increases expression |
EXP |
glycidol results in increased expression of PCDHGA11 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:29,583,373...29,667,865
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pcdhga5 |
protocadherin gamma subfamily A, 5 |
increases expression |
EXP |
glycidol results in increased expression of PCDHGA5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:29,519,705...29,667,865
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pcdhga7 |
protocadherin gamma subfamily A, 7 |
increases expression |
EXP |
glycidol results in increased expression of PCDHGA7 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:29,543,018...29,667,865
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pcdhga9 |
protocadherin gamma subfamily A, 9 |
increases expression |
EXP |
glycidol results in increased expression of PCDHGA9 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:29,564,614...29,667,865
|
|
G |
Pcdhgb7 |
protocadherin gamma subfamily B, 7 |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of PCDHGB7 mRNA glycidol results in increased expression of PCDHGB7 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:29,579,129...29,667,868
Ensembl chr18:29,493,954...29,667,868
|
|
G |
Pcf11 |
PCF11 cleavage and polyadenylation factor subunit |
decreases expression |
EXP |
glycidol results in decreased expression of PCF11 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:146,694,045...146,724,030
Ensembl chr 1:146,697,646...146,724,124
|
|
G |
Pclaf |
PCNA clamp associated factor |
decreases expression |
EXP |
glycidol results in decreased expression of PCLAF mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
increases expression |
EXP |
glycidol results in increased expression of PCSK1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
|
|
G |
Pde1c |
phosphodiesterase 1C |
decreases expression |
EXP |
glycidol results in decreased expression of PDE1C mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:85,300,858...85,777,948
Ensembl chr 4:85,300,858...85,863,219
|
|
G |
Pdgfd |
platelet derived growth factor D |
increases expression |
EXP |
glycidol results in increased expression of PDGFD mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:3,488,448...3,722,395
Ensembl chr 8:3,488,423...3,722,395
|
|
G |
Pdlim2 |
PDZ and LIM domain 2 |
increases expression |
EXP |
glycidol results in increased expression of PDLIM2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242
|
|
G |
Perm1 |
PPARGC1 and ESRR induced regulator, muscle 1 |
increases expression |
EXP |
glycidol results in increased expression of PERM1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:166,800,030...166,805,323
Ensembl chr 5:166,800,030...166,805,323
|
|
G |
Phactr2 |
phosphatase and actin regulator 2 |
increases expression |
EXP |
glycidol results in increased expression of PHACTR2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:7,591,254...7,860,431
Ensembl chr 1:7,597,927...7,860,289
|
|
G |
Phf11 |
PHD finger protein 11 |
increases expression |
EXP |
glycidol results in increased expression of PHF11 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:33,390,290...33,414,647
Ensembl chr15:33,390,292...33,413,009
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
increases expression |
EXP |
glycidol results in increased expression of PIM1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
|
|
G |
Pimreg |
PICALM interacting mitotic regulator |
decreases expression |
EXP |
glycidol results in decreased expression of PIMREG mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:56,669,603...56,674,540
Ensembl chr10:56,669,675...56,674,791
|
|
G |
Piwil2 |
piwi-like RNA-mediated gene silencing 2 |
decreases expression |
EXP |
glycidol results in decreased expression of PIWIL2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
increases expression |
EXP |
glycidol results in increased expression of PKMYT1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995
|
|
G |
Pkp2 |
plakophilin 2 |
increases expression |
EXP |
glycidol results in increased expression of PKP2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr11:84,661,783...84,727,730
Ensembl chr11:84,661,783...84,727,730
|
|
G |
Pla1a |
phospholipase A1 member A |
increases expression |
EXP |
glycidol results in increased expression of PLA1A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779
|
|
G |
Pla2g2d |
phospholipase A2, group IID |
increases expression |
EXP |
glycidol results in increased expression of PLA2G2D mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:151,016,010...151,022,531
Ensembl chr 5:151,018,870...151,022,525
|
|
G |
Pla2g3 |
phospholipase A2, group III |
affects expression decreases expression |
EXP |
glycidol affects the expression of PLA2G3 mRNA glycidol results in decreased expression of PLA2G3 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr14:78,367,625...78,373,913
Ensembl chr14:78,368,105...78,373,913
|
|
G |
Pla2g4c |
phospholipase A2 group IVC |
increases expression |
EXP |
glycidol results in increased expression of PLA2G4C mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:74,237,714...74,275,757
Ensembl chr 1:74,236,211...74,274,656
|
|
G |
Pla2g5 |
phospholipase A2, group V |
increases expression |
EXP |
glycidol results in increased expression of PLA2G5 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
|
|
G |
Pld3 |
phospholipase D family, member 3 |
increases expression |
ISO |
glycidol results in increased expression of PLD3 mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 1:82,821,863...82,844,280
Ensembl chr 1:82,821,875...82,844,072
|
|
G |
Plek2 |
pleckstrin 2 |
decreases expression |
EXP |
glycidol results in decreased expression of PLEK2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326
|
|
G |
Plk4 |
polo-like kinase 4 |
affects expression |
EXP |
glycidol affects the expression of PLK4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:123,802,527...123,820,942
Ensembl chr 2:123,802,512...123,820,942
|
|
G |
Plppr3 |
phospholipid phosphatase related 3 |
decreases expression |
EXP |
glycidol results in decreased expression of PLPPR3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:9,831,162...9,842,434
Ensembl chr 7:9,831,162...9,845,296
|
|
G |
Plppr5 |
phospholipid phosphatase related 5 |
decreases expression |
EXP |
glycidol results in decreased expression of PLPPR5 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:205,525,466...205,737,892
Ensembl chr 2:205,458,176...205,717,599
|
|
G |
Plxnd1 |
plexin D1 |
decreases expression |
EXP |
glycidol results in decreased expression of PLXND1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:149,002,786...149,043,097
Ensembl chr 4:149,002,784...149,043,244
|
|
G |
Pnma8b |
PNMA family member 8B |
increases expression |
EXP |
glycidol results in increased expression of PNMA8B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:77,622,287...77,626,525
Ensembl chr 1:77,622,283...77,627,148
|
|
G |
Pnpla1 |
patatin-like phospholipase domain containing 1 |
increases expression |
EXP |
glycidol results in increased expression of PNPLA1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr20:6,917,993...6,952,157
Ensembl chr20:6,917,931...6,952,375
|
|
G |
Pou2af2 |
POU class 2 homeobox associating factor 2 |
decreases expression |
EXP |
glycidol results in decreased expression of POU2AF2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:51,607,780...51,648,790
Ensembl chr 8:51,607,763...51,648,628
|
|
G |
Pou3f4 |
POU class 3 homeobox 4 |
increases expression |
EXP |
glycidol results in increased expression of POU3F4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr X:75,858,646...75,859,923
Ensembl chr X:75,858,646...75,859,923
|
|
G |
Ppic |
peptidylprolyl isomerase C |
decreases expression |
EXP |
glycidol results in decreased expression of PPIC mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:46,842,410...46,855,016
Ensembl chr18:46,842,409...46,855,017
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
decreases expression |
EXP |
glycidol results in decreased expression of PPP1R15A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
increases expression |
EXP |
glycidol results in increased expression of PPP1R1B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
|
|
G |
Ppp1r1c |
protein phosphatase 1, regulatory (inhibitor) subunit 1C |
decreases expression |
ISO |
glycidol results in decreased expression of PPP1R1C mRNA |
CTD |
PMID:15612046 |
|
NCBI chr 3:64,616,700...64,719,696
Ensembl chr 3:64,616,700...64,724,104
|
|
G |
Prag1 |
PEAK1 related kinase activating pseudokinase 1 |
increases expression |
EXP |
glycidol results in increased expression of PRAG1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr16:56,087,885...56,141,153
Ensembl chr16:56,087,885...56,141,153
|
|
G |
Pramef12 |
PRAME family member 12 |
decreases expression |
EXP |
glycidol results in decreased expression of PRAMEF12 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 5:156,193,666...156,197,199
Ensembl chr 5:156,193,745...156,197,195
|
|
G |
Prb1 |
proline-rich protein BstNI subfamily 1 |
increases expression |
EXP |
glycidol results in increased expression of PRB1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:165,508,927...165,512,393
Ensembl chr 4:165,509,298...165,512,393
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
decreases expression |
EXP |
glycidol results in decreased expression of PRC1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
|
|
G |
Prelid2 |
PRELI domain containing 2 |
decreases expression |
EXP |
glycidol results in decreased expression of PRELID2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:33,869,934...33,961,320
Ensembl chr18:33,873,599...33,961,225
|
|
G |
Prlr |
prolactin receptor |
increases expression |
EXP |
glycidol results in increased expression of PRLR mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Proca1 |
protein interacting with cyclin A1 |
decreases expression |
EXP |
glycidol results in decreased expression of PROCA1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:63,090,018...63,102,941
Ensembl chr10:63,090,018...63,102,940
|
|
G |
Prom1 |
prominin 1 |
decreases expression |
EXP |
glycidol results in decreased expression of PROM1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr14:66,989,545...67,094,534
Ensembl chr14:66,990,160...67,094,527
|
|
G |
Proser2 |
proline and serine rich 2 |
decreases expression |
EXP |
glycidol results in decreased expression of PROSER2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:72,151,961...72,187,524
Ensembl chr17:72,151,872...72,185,825
|
|
G |
Prpf38b |
pre-mRNA processing factor 38B |
decreases expression |
EXP |
glycidol results in decreased expression of PRPF38B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:196,553,224...196,562,271
Ensembl chr 2:196,553,225...196,562,250
|
|
G |
Prr15 |
proline rich 15 |
increases expression |
EXP |
glycidol results in increased expression of PRR15 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:83,432,002...83,435,582
Ensembl chr 4:83,431,758...83,437,436
|
|
G |
Prr16 |
proline rich 16 |
decreases expression |
EXP |
glycidol results in decreased expression of PRR16 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:44,424,348...44,764,796
Ensembl chr18:44,424,616...44,632,329
|
|
G |
Prr32 |
proline rich 32 |
affects expression |
EXP |
glycidol affects the expression of PRR32 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr X:123,978,010...123,979,928
Ensembl chr X:123,977,985...123,979,942
|
|
G |
Prss39 |
protease, serine, 39 |
increases expression |
EXP |
glycidol results in increased expression of PRSS39 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 9:36,695,037...36,713,004
Ensembl chr 9:36,707,328...36,713,001
|
|
G |
Psca |
prostate stem cell antigen |
increases expression |
ISO |
glycidol results in increased expression of PSCA mRNA |
CTD |
PMID:33187795 |
|
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
|
|
G |
Psen1 |
presenilin 1 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of PSEN1 promoter glycidol results in decreased expression of PSEN1 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
|
|
G |
Psmb9 |
proteasome 20S subunit beta 9 |
decreases expression |
EXP |
glycidol results in decreased expression of PSMB9 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
|
|
G |
Pter |
phosphotriesterase related |
increases expression |
EXP |
glycidol results in increased expression of PTER mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:76,058,388...76,119,633
Ensembl chr17:76,058,503...76,119,627
|
|
G |
Ptgds |
prostaglandin D2 synthase |
decreases expression |
EXP |
glycidol results in decreased expression of PTGDS mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
EXP |
glycidol results in decreased expression of PTGS2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
increases expression |
EXP |
glycidol results in increased expression of PTPN1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
increases expression |
EXP |
glycidol results in increased expression of PTPRC mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
|
|
G |
Ptprj |
protein tyrosine phosphatase, receptor type, J |
increases expression |
EXP |
glycidol results in increased expression of PTPRJ mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:76,405,917...76,561,842
Ensembl chr 3:76,405,927...76,562,260
|
|
G |
Ptpru |
protein tyrosine phosphatase, receptor type, U |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of PTPRU promoter glycidol results in decreased expression of PTPRU mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 5:143,950,542...144,024,791
Ensembl chr 5:143,950,965...144,024,768
|
|
G |
Pvalb |
parvalbumin |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of PVALB mRNA glycidol results in increased methylation of PVALB promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 7:109,772,939...109,787,954
Ensembl chr 7:109,772,593...109,784,561
|
|
G |
Pvr |
PVR cell adhesion molecule |
decreases expression |
EXP |
glycidol results in decreased expression of PVR mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
|
|
G |
Pwwp3b |
PWWP domain containing 3B |
increases expression |
EXP |
glycidol results in increased expression of PWWP3B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr X:102,804,416...102,838,580
Ensembl chr X:102,804,520...102,838,574
|
|
G |
Rab38 |
RAB38, member RAS oncogene family |
increases expression |
EXP |
glycidol results in increased expression of RAB38 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:142,182,566...142,262,923
Ensembl chr 1:142,182,556...142,262,924
|
|
G |
Rad51b |
RAD51 paralog B |
decreases expression |
EXP |
glycidol results in decreased expression of RAD51B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
|
|
G |
Ralgps2 |
Ral GEF with PH domain and SH3 binding motif 2 |
decreases expression |
EXP |
glycidol results in decreased expression of RALGPS2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:68,924,674...69,104,637
Ensembl chr13:68,928,474...69,056,549
|
|
G |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
decreases expression |
EXP |
glycidol results in decreased expression of RASGRF1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 8:90,445,154...90,574,274
Ensembl chr 8:90,445,154...90,574,269
|
|
G |
Rasgrp4 |
RAS guanyl releasing protein 4 |
decreases expression |
EXP |
glycidol results in decreased expression of RASGRP4 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:84,433,033...84,452,841
Ensembl chr 1:84,433,064...84,451,896
|
|
G |
Rasl11a |
RAS-like family 11 member A |
decreases expression |
EXP |
glycidol results in decreased expression of RASL11A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr12:8,258,148...8,260,909
Ensembl chr12:8,258,159...8,262,576
|
|
G |
Rassf1 |
Ras association domain family member 1 |
affects expression affects methylation |
EXP |
glycidol affects the expression of RASSF1 mRNA glycidol affects the methylation of RASSF1 promoter |
CTD |
PMID:27884059 |
|
NCBI chr 8:108,225,023...108,236,164
Ensembl chr 8:108,225,023...108,236,164
|
|
G |
Rassf4 |
Ras association domain family member 4 |
increases expression |
EXP |
glycidol results in increased expression of RASSF4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:149,897,525...149,932,658
Ensembl chr 4:149,897,543...149,932,411
|
|
G |
Rbm24 |
RNA binding motif protein 24 |
decreases expression |
EXP |
glycidol results in decreased expression of RBM24 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr17:18,275,681...18,288,231
Ensembl chr17:18,275,688...18,288,102
|
|
G |
Rbm38 |
RNA binding motif protein 38 |
increases expression |
EXP |
glycidol results in increased expression of RBM38 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:161,801,577...161,814,381
Ensembl chr 3:161,801,577...161,814,381
|
|
G |
Recql4 |
RecQ like helicase 4 |
increases expression |
EXP |
glycidol results in increased expression of RECQL4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619
|
|
G |
Ren |
renin |
decreases expression |
EXP |
glycidol results in decreased expression of REN mRNA |
CTD |
PMID:24915197 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rfx2 |
regulatory factor X2 |
increases expression |
EXP |
glycidol results in increased expression of RFX2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 9:1,604,636...1,671,220
Ensembl chr 9:1,604,646...1,671,027
|
|
G |
Rfx5 |
regulatory factor X5 |
increases expression |
EXP |
glycidol results in increased expression of RFX5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:182,521,191...182,528,720
Ensembl chr 2:182,521,202...182,528,717
|
|
G |
RGD1309362 |
similar to interferon-inducible GTPase |
decreases expression |
EXP |
glycidol results in decreased expression of RGD1309362 mRNA |
CTD |
PMID:24395379 |
|
|
|
G |
Rgr |
retinal G protein coupled receptor |
decreases expression |
EXP |
glycidol results in decreased expression of RGR mRNA |
CTD |
PMID:24395379 |
|
NCBI chr16:12,801,594...12,816,402
Ensembl chr16:12,801,594...12,816,223
|
|
G |
Rhod |
ras homolog family member D |
decreases expression |
EXP |
glycidol results in decreased expression of RHOD mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 1:201,708,699...201,724,405
Ensembl chr 1:201,708,699...201,722,632
|
|
G |
Rims3 |
regulating synaptic membrane exocytosis 3 |
decreases expression |
EXP |
glycidol results in decreased expression of RIMS3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:134,429,092...134,468,935
Ensembl chr 5:134,435,829...134,640,489
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
increases phosphorylation multiple interactions |
EXP |
glycidol results in increased phosphorylation of RIPK3 protein [glycidol co-treated with alpha-Chlorohydrin] results in increased phosphorylation of RIPK3 protein |
CTD |
PMID:33187795 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Ripor3 |
RIPOR family member 3 |
increases expression |
EXP |
glycidol results in increased expression of RIPOR3 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 3:156,687,253...156,760,524
Ensembl chr 3:156,687,517...156,715,061
|
|
G |
Rnase12 |
ribonuclease A family member 12 |
decreases expression |
EXP |
glycidol results in decreased expression of RNASE12 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr15:24,275,767...24,286,843
Ensembl chr15:24,275,774...24,276,702
|
|
G |
Rnasek |
ribonuclease K |
increases expression |
EXP |
glycidol results in increased expression of RNASEK mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:54,954,904...54,956,622
Ensembl chr10:54,951,991...54,956,601
|
|
G |
Rnd3 |
Rho family GTPase 3 |
decreases expression |
EXP |
glycidol results in decreased expression of RND3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
|
|
G |
Rnf11 |
ring finger protein 11 |
decreases expression |
EXP |
glycidol results in decreased expression of RNF11 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:124,212,433...124,243,125
Ensembl chr 5:124,212,445...124,234,750
|
|
G |
Ros1 |
ROS proto-oncogene 1 , receptor tyrosine kinase |
decreases expression |
EXP |
glycidol results in decreased expression of ROS1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:31,432,636...31,583,998
Ensembl chr20:31,432,637...31,583,865
|
|
G |
Rph3al |
rabphilin 3A-like (without C2 domains) |
increases expression |
EXP |
glycidol results in increased expression of RPH3AL mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:60,689,943...60,833,354
Ensembl chr10:60,690,031...60,801,883
|
|
G |
Rpl39l1 |
ribosomal protein L39 like 1 |
increases expression |
EXP |
glycidol results in increased expression of RPL39L mRNA |
CTD |
PMID:24395379 |
|
NCBI chr10:5,455,712...5,459,828
Ensembl chr10:5,454,559...5,462,029
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
decreases expression |
EXP |
glycidol results in decreased expression of RRM2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
decreases expression |
EXP |
glycidol results in decreased expression of RSAD2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:43,046,514...43,059,737
Ensembl chr 6:43,047,658...43,059,699
|
|
G |
Rsph10b |
radial spoke head 10 homolog B |
increases expression |
EXP |
glycidol results in increased expression of RSPH10B mRNA |
CTD |
PMID:24395379 |
|
NCBI chr12:10,627,434...10,675,227
Ensembl chr12:10,627,435...10,675,167
|
|
G |
Rsrp1 |
arginine and serine rich protein 1 |
decreases expression |
EXP |
glycidol results in decreased expression of RSRP1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
|
|
G |
RT1-Bb |
RT1 class II, locus Bb |
increases expression |
EXP |
glycidol results in increased expression of RT1-BB mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
|
|
G |
RT1-CE4 |
RT1 class I, locus CE4 |
increases expression |
EXP |
glycidol results in increased expression of RT1-CE4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr20:3,431,509...3,504,535
|
|
G |
RT1-Cl |
RT1 class Ib, locus Cl |
decreases expression |
EXP |
glycidol results in decreased expression of RT1-CL mRNA |
CTD |
PMID:24395379 |
|
|
|
G |
RT1-T18 |
RT1 class Ib, locus T18 |
increases expression |
EXP |
glycidol results in increased expression of RT1-T18 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr20:2,605,261...2,608,909
Ensembl chr20:2,605,265...2,608,909
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
increases expression |
EXP |
glycidol results in increased expression of RUNX2 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
increases expression |
EXP |
glycidol results in increased expression of RUNX3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Rxfp3 |
relaxin family peptide receptor 3 |
decreases expression |
EXP |
glycidol results in decreased expression of RXFP3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:60,003,256...60,004,686
Ensembl chr 2:60,003,256...60,004,686
|
|
G |
Rxra |
retinoid X receptor alpha |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of RXRA mRNA glycidol results in increased methylation of RXRA promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
S100a13 |
S100 calcium binding protein A13 |
decreases expression |
EXP |
glycidol results in decreased expression of S100A13 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:175,999,439...176,005,933
|
|
G |
S100a3 |
S100 calcium binding protein A3 |
decreases expression |
EXP |
glycidol results in decreased expression of S100A3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
|
|
G |
S100a4 |
S100 calcium-binding protein A4 |
decreases expression |
EXP |
glycidol results in decreased expression of S100A4 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
|
|
G |
S100a6 |
S100 calcium binding protein A6 |
increases expression multiple interactions |
EXP ISO |
glycidol results in increased expression of S100A6 mRNA [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of S100A6 mRNA |
CTD |
PMID:24915197 PMID:33187795 |
|
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
|
|
G |
S1pr5 |
sphingosine-1-phosphate receptor 5 |
decreases expression |
EXP |
glycidol results in decreased expression of S1PR5 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 8:19,786,676...19,791,862
Ensembl chr 8:19,786,663...19,791,795
|
|
G |
Sall3 |
spalt-like transcription factor 3 |
decreases expression |
EXP |
glycidol results in decreased expression of SALL3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr18:74,406,066...74,425,974
Ensembl chr18:74,407,560...74,426,789
|
|
G |
Scara3 |
scavenger receptor class A, member 3 |
decreases expression increases expression |
EXP |
glycidol results in decreased expression of SCARA3 mRNA glycidol results in increased expression of SCARA3 mRNA |
CTD |
PMID:24395379 PMID:24915197 |
|
NCBI chr15:40,139,873...40,172,866
Ensembl chr15:40,140,161...40,172,894
|
|
G |
Scara5 |
scavenger receptor class A, member 5 |
increases expression |
EXP |
glycidol results in increased expression of SCARA5 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:39,880,017...39,985,007
Ensembl chr15:39,880,035...39,983,373
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
EXP |
glycidol results in decreased expression of SCD1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scin |
scinderin |
decreases expression |
EXP |
glycidol results in decreased expression of SCIN mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 6:57,109,500...57,188,123
Ensembl chr 6:57,109,403...57,188,242
|
|
G |
Selenov |
selenoprotein V |
decreases expression |
EXP |
glycidol results in decreased expression of SELENOV mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:83,551,473...83,558,756
Ensembl chr 1:83,551,473...83,558,756
|
|
G |
Sema3b |
semaphorin 3B |
decreases expression increases methylation |
EXP |
glycidol results in decreased expression of SEMA3B mRNA glycidol results in increased methylation of SEMA3B promoter |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 8:108,271,663...108,280,326
Ensembl chr 8:108,271,666...108,282,919
|
|
G |
Sema3c |
semaphorin 3C |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of SEMA3C promoter glycidol results in decreased expression of SEMA3C mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
|
|
G |
Sema4b |
semaphorin 4B |
decreases expression |
EXP |
glycidol results in decreased expression of SEMA4B mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:134,136,646...134,177,777
Ensembl chr 1:134,149,536...134,177,775
|
|
G |
Sema5a |
semaphorin 5A |
increases expression |
EXP |
glycidol results in increased expression of SEMA5A mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084
|
|
G |
Septin10 |
septin 10 |
decreases expression |
EXP |
glycidol results in decreased expression of SEPTIN10 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780
|
|
G |
Serpina11 |
serpin family A member 11 |
increases expression |
EXP |
glycidol results in increased expression of SERPINA11 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 6:122,903,246...122,912,695
Ensembl chr 6:122,903,250...122,912,670
|
|
G |
Serpina3n |
serpin family A member 3N |
increases expression |
EXP |
glycidol results in increased expression of SERPINA3N mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
|
|
G |
Sfrp5 |
secreted frizzled-related protein 5 |
decreases expression |
EXP |
glycidol results in decreased expression of SFRP5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:241,006,762...241,011,224
Ensembl chr 1:241,006,762...241,011,224
|
|
G |
Sgcg |
sarcoglycan, gamma |
decreases expression |
EXP |
glycidol results in decreased expression of SGCG mRNA |
CTD |
PMID:24395379 |
|
NCBI chr15:35,388,836...35,435,072
Ensembl chr15:35,386,534...35,435,148
|
|
G |
Sgms2 |
sphingomyelin synthase 2 |
decreases expression |
EXP |
glycidol results in decreased expression of SGMS2 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 2:219,889,809...219,967,704
Ensembl chr 2:219,893,572...219,967,546
|
|
G |
Sh2d3c |
SH2 domain containing 3C |
decreases expression |
EXP |
glycidol results in decreased expression of SH2D3C mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 3:16,010,622...16,046,491
Ensembl chr 3:16,010,625...16,046,484
|
|
G |
Shc1 |
SHC adaptor protein 1 |
increases expression |
EXP |
glycidol results in increased expression of SHC1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Six4 |
SIX homeobox 4 |
increases methylation decreases expression |
EXP |
glycidol results in increased methylation of SIX4 promoter glycidol results in decreased expression of SIX4 mRNA |
CTD |
PMID:33150595 PMID:33150645 |
|
NCBI chr 6:91,802,328...91,816,002
Ensembl chr 6:91,802,329...91,815,992
|
|
G |
Ska1 |
spindle and kinetochore associated complex subunit 1 |
decreases expression |
EXP |
glycidol results in decreased expression of SKA1 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037
|
|
G |
Sla |
src-like adaptor |
increases expression |
EXP |
glycidol results in increased expression of SLA mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:98,535,368...98,584,648
|
|
G |
Slc11a1 |
solute carrier family 11 member 1 |
increases expression |
EXP |
glycidol results in increased expression of SLC11A1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
|
|
G |
Slc12a8 |
solute carrier family 12, member 8 |
decreases expression |
EXP |
glycidol results in decreased expression of SLC12A8 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr11:67,116,876...67,266,548
Ensembl chr11:67,116,877...67,266,834
|
|
G |
Slc13a1 |
solute carrier family 13 member 1 |
increases expression |
EXP |
glycidol results in increased expression of SLC13A1 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 4:52,569,179...52,647,126
Ensembl chr 4:52,569,375...52,647,099
|
|
G |
Slc13a5 |
solute carrier family 13 member 5 |
decreases expression |
EXP |
glycidol results in decreased expression of SLC13A5 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:56,866,249...56,891,189
Ensembl chr10:56,866,249...56,890,945
|
|
G |
Slc16a3 |
solute carrier family 16 member 3 |
increases expression |
EXP |
glycidol results in increased expression of SLC16A3 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr10:106,212,679...106,222,564
Ensembl chr10:106,212,778...106,222,562
|
|
G |
Slc16a8 |
solute carrier family 16 member 8 |
increases expression |
EXP |
glycidol results in increased expression of SLC16A8 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:110,818,274...110,822,069
Ensembl chr 7:110,818,274...110,822,069
|
|
G |
Slc17a6 |
solute carrier family 17 member 6 |
decreases expression |
EXP |
glycidol results in decreased expression of SLC17A6 mRNA |
CTD |
PMID:24915197 |
|
NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
|
|
G |
Slc1a6 |
solute carrier family 1 member 6 |
increases expression |
EXP |
glycidol results in increased expression of SLC1A6 mRNA |
CTD |
PMID:24395379 |
|
NCBI chr 7:10,841,836...10,870,424
Ensembl chr 7:10,841,837...10,870,449
| |